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Preface 
CDC has published a State Health Profile for each state and the District of Columbia every year 
since 1987. This publication series is designed to consolidate the most current data on the health 
of the U.S. population, the availability and use of health resources, and the distribution of CDC’s 
health-care xpenditures throughout the country. 
The information presented in this publication series also highlights CDC’s collaborative efforts 
with public health partners at the federal, state, and local levels, which have lead to a range of 
major public health achievements this century. These achievements include record low rates for 
many childhood vaccine-preventable diseases, healthier mothers and infants, safer and healthier 
food, safer workplaces, fluoridated drinking water, control of infectious diseases, declines in 
heart disease and stroke deaths rates, and the recognition of tobacco use as a health hazard. 
By providing meaningful public health information to policymakers and the public through the 
annual State Health Profile, CDC strives to continue its efforts to improve the nation’s health. 
We hope you will find this publication series useful. 
This project is made possible each year by the contributions of staff members throughout CDC 
and in state health departments. We appreciate their invaluable support. 
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Health Status Indicators 
Data presented in this publication are based on a list of 18 health status indicators established by 
a national committee.* These health status indicators are intended to ensure data comparability 
across the states and to help communities assess their general health status. 
Acquired Immunodeficiency Syndrome (AIDS) .................................... 34 
AirQualityStandards ........................................................ 22 
AllLeadingCausesofDeaths ................................................ ..2- 5 
Birth Rates for Females Aged lo-17 Years ....................................... xii 
Cardiovascular Disease Deaths ................................................. 45 
ChildhoodPoverty .......................................................... xii 
Female Breast Cancer Deaths .................................................. 46 
Homicide .................................................................. 20 
Infant Mortality .......................................................... 12-13 
LowBirthweight ........................................................... ..12 
LungCancerDeaths ......................................................... 48 
Measles ................................................................... 11 
Motor Vehicle-Related Deaths ................................................. 18 
Prenatal&-e ............................................................... 14 
Primary and Secondary Syphilis ................................................ 37 
Suicide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 
Tuberculosis ............................................................... 40 
Work-Related Injury Deaths ................................................ 28-3 1 
. 
* CDC. Consensus set of health status indicators for the general assessment of community health status - United 
States. A4A4WR 199 1;40:449-5 1. 
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The District of Columbia and CDC in Partnership 
CDC works with state and local health departments, educational institutions, and other private and 
public organizations in the District of Columbia to carry out CDC’s mission to promote health and 
quality of life by preventing and controlling disease, injury, and disability. Listed below are some of the 
programs and projects that represent his partnership, as well as other programs and services provided by 
CDC throughout the United States. 
Provided technical assistance and a resource 
guide to all 50 states and the District of 
Columbia to develop, implement, and evalu- 
ate childhood lead surveillance programs. 
Provided training packets and teleconferences 
to all 50 states on asthma surveillance, inter- 
ventions, education, and coalitions. 
Collected and published data from all 50 
states, New York City, and the District of 
Columbia on births, deaths, marriages, and 
divorces through the Vital Statistics Coopera- 
tive Program of the National Vital-Statistics 
System. 
Provided voluntary laboratory performance 
evaluation programs for human immunodefi- 
ciency virus (HIV) and multidrug-resistant 
tuberculosis testing. 
Provided technical and financial support for 
states to implement strategies to reach per- 
sons at highest risk for underimmunization. 
Provided technical and financial support for 
states to improve immunization coverage 
through provider-based Assessment, Feed- 
back, Incentive, and Exchange (AFIX) activi- 
ties, emphasizing private-sector immuniza- 
tion providers. 
Evaluated the safety and health risks for 
emergency response workers to identify their 
needs and potential hazards. 
Funded the health department o implement 
tobacco-use control and prevention programs 
($347,285). . 
Collaborated with and awarded cooperative 
agreement funds to the District of Columbia 
and all 50 states for breast and cervical cancer 
screening through the National Breast and 
Cervical Cancer Early Detection Program. 
Designed and supported graduate-level train- 
ing in work organization, stress, and health at 
universities in cooperation with the American 
Psychological Association. 
Tested for inadequate air circulation and mi- 
crobial contamination at a government office 
building. 
Funded a statewide Core Diabetes Control 
Program ($100,000). 
Provided funds and technical assistance to the 
state health department for West Nile Virus 
surveillance and enhanced laboratory capacity. 
Consulted on the risk for transmission of 
bloodborne pathogens in health-care settings. 
Provided laboratory expertise for assessing 
sexually transmitted disease programs as part 
of the National Plan for Syphilis Elimination. 
Funded the Center for Law and the Public’s 
Health, a CDC Center for Public Health Pre- 
paredness, at Georgetown University Law 
Center and Johns Hopkins University 
(Maryland) ($300,000). 
Provided immunization materials to states in 
English and Spanish by mail, E-mail, fax, and 
the Internet. 
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lealth Information and Guidelines 
Sample of Services Provided by 
Developing recommendations and guidelines to create healthy workplaces. 
Developing the CDC Prevention Guidelines Database. 
Providing materials for a folic acid educational campaign to implement the Public Health Service (PHS) 
recommendation that all women capable of having children consume 400 mg of folic acid daily. Information 
is available in English or Spanish for two target audiences (i.e., women thinking about pregnancy and women 
not thinking about pregnancy) and can be ordered by E-mail from the following address: <Flo@cdc.gov>. 
Developing model language for asthma care that state Medicaid programs can use when contracting with 
health-care providers (e.g., managed-care organizations). 
Published Best Practices to Prevent Violence by Children and Adolescents: A Sourcebook, a planning guide 
for communities seeking practical, comprehensive guidance in building a program to prevent violence by 
children and adolescents through a public health approach. 
Providing quality counter-advertising materials (for television, radio, theater, print, and outdoor ads) and 
technical assistance in media planning and buying to states and nonprofit organizations nationwide through 
the Media Campaign Resource Center for Tobacco Control. Organizations in all states and the District of 
Columbia have used these materials as paid ads and as public service announcements. 
Providing training and guidance to state and local health departments, including helping public health 
laboratories develop comprehensive bioterrorism preparedness and response programs. 
Publishing health information for international travelers, including on the Internet at 
<http://www.cdc.gov/ravel/>. 
Providing through SafeUSA a centralized source of safety-related information to inform U.S. residents of 
what injury prevention measures work and how to access resources designed to help persons and groups 
prevent injuries in their personal lives and communities. 
Helping prevent and control human immunodeficiency virus (HIV) infection and acquired immunodeticiency 
syndrome (AIDS) through education, testing and counseling, and risk-reduction programs. 
Publishing the Morbidity and Mortalig Weekly Report, Recommendations and Reports, and CDC 
Surveillance Summaries. 
nvestigations and Emergency Response 
l Responding to national and international emergencies, including natural disasters (e.g., hurricanes, 
earthquakes) and displaced populations. 
l Investigating outbreaks of an environmental nature (e.g., foodborne) for disease and clusters of other public 
health problems. 
l Developed an interim communications system to alert state health departments of possible bioterrorism 
attacks and other health threats through broadcast fax and E-mail. 
l Conducting field investigations of possible health hazards in the workplace in response to worker or employer 
requests. 
l Investigating outbreaks of infectious diseases and clusters of other public health problems. 
l Helping states investigate suspected bioterrorist events. 
Bublic Health Surveillance and Statistics 
Providing technical and financial assistance for the Behavioral Risk Factor Surveillance System (BRFSS), a 
state-based surveillance system active in all 50 states and the District of Columbia. This system is the 
primary source for state-based information on risk behaviors among adult populations. 
Improving disease and vaccination surveillance by supporting systems that monitor disease trends, assess 
vaccine coverage, and monitor adverse events. 
Collaborating on state-based surveillance systems. 
Conducted a pilot test of the State and Local Area Integrated Telephone Survey (SLAITS) module on 
Children’s Well-Being and Welfare with the Texas Department of Health. This module included a Medicaid- 
linkage experiment o establish a method of identifying current Medicaid enrollees. 
Funding capacity-building projects for disability-related health promotion, secondary condition prevention, 
and surveillance in the District of Columbia and 15 states (Alabama, Arkansas, Colorado, Iowa, Kansas, 
Massachusetts, Missouri, New Mexico, New York, North Carolina, Oregon, Rhode Island, South Carolina, 
Texas, and Washington), which use BRFSS data to identify persons with disabilities and collect data on their 
health status and quality of life. 
ix 
‘CDC Throughout the United States 
. Providing the State Tobacco Activities Tracking and Evaluation (STATE) System, an Internet-based 
electronic data warehouse of up-to-date and historical state-level data on tobacco use prevention and control. 
This user-friendly system, available to all states through the Internet, integrates multiple sources of 
comprehensive summary data to direct program efforts and demonstrate accountability. 
l Collaborating with state and local health departments on effective surveillance and intervention programs, 
including those aimed at emerging public health problems. 
. Coordinating PulseNet, a public health laboratory network for rapid identification of foodborne disease 
outbreaks. 
. Collaborating with state and local health departments on effective surveillance and intervention programs, 
including ones aimed at emerging public health problems. 
. Expanded the National Electronic Injury Surveillance System (NEISS) to begin collecting national data from 
emergency departments on nonfatal injuries from all causes. Previously, NEISS collected data only on 
injuries related to consumer products. 
Technical Assistance and Funding 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
Ensuring effective immunization se&ices by a) offering programmatic, technical, epidemiologic, and 
scientific assistance to state and local areas, b) awarding grants to states and large local health departments, 
and c) providing funds and technical assistance to states for population-based immunization registries. 
Helped establish and improve birth defects monitoring programs, investigate clusters of birth defects, and 
implement prevention programs for selected birth defects. 
Providing funds for 11 extramural research grants designed to a) measure the magnitude of secondary 
conditions among specified populations of persons with disabilities; b) determine the risk and protective 
factors that contribute to or avert the occurrence of secondary conditions; c) conduct and measure the 
effectiveness of health promotion interventions designed to prevent secondary conditions; and d) understand 
the prevention effectiveness and cost-effectiveness of interventions. 
Providing expert testimony to state legislatures and state-based organizations regarding the scientific 
evidence supporting public health interventions to prevent tobacco use and issuing recommendations for a 
comprehensive public health approach to tobacco use prevention and control. 
Providing technical assistance and funds to support development of new electronic information tools for 
improved public health services. 
Providing technical assistance and consultation to state and local health departments to improve their 
effectiveness through the National Public Health Performance Standards Program. 
Administering the Preventive Health and Health Services Block Grant. 
Administering the Bioterrorism Preparedness and Response Cooperative Agreement. 
Assigning Public Health Advisors/Specialists, Epidemic Intelligence Officers, and Preventive Medicine 
Residents to state and local health departments. 
Provided financial and technical assistance to 39 states and 4 local health departments through the 
Epidemiology and Laboratory Capacity Program to strengthen public health capacity for infectious disease 
surveillance and response. 
Providing funds through cooperative agreements and technical assistance to all states and some cities for 
tuberculosis screening, prevention, and treatment services. 
Training 
l Providing all states with asthma training modules and teleconferences. 
l Provided immunization training and education, including continuing education credits, to states through 
onsite courses, satellite broadcasts, and remote audio, video, and webcasts. 
l Conducted the Tobacco Control Summer Institute to build the capacity of states and communities to 
implement state-of-the-art surveillance and intervention programs. 
l Helping states and other countries strengthen their public health practices through laboratory, epidemiology, 
and communications training. 
l Funding the West Virginia Training and Demonstration Center to implement a statewide program of 
education and applied research to improve the health and reduce the incidence of injury in rural West 
Virginia communities. 
l Helping state and local partners prepare for and respond to bioterrorism by providing training in laboratory 
capability, preparedness planning, emergency response, surveillance, and information technology. 
X 
Bioterrorism Preparedness and Response 
CDC Funding for Fiscal Year 2000 
/ Prc / \ 
- ’ 
A,B,C 
MA B,C,E 
MD B,C 
NH C,E 
NJ B,C,E 
RI B,C,E 
VT E 
Funding Focus Areas 
A = Preparedness Planning and Readiness Assessment 
B = Epidemiology and Surveillance Capacity 
C = Laboratory Capacity for Biologic Agents 
D = Laboratory Capacity for Chemical Agents 
E = Health Alert Network (HAN)/Training 
A = Electronic Communications/HAN Exemplar Projects 
Denver, CO 
DeKalb County, GA 
Monroe County, NY 
. 
Note: Federal fiscal year 2000 = October 1, 1999, through September 30,200O. 
Source: Bioterrorism Preparedness and Response Program, National Center 
for Infectious Diseases, CDC. 
CDC Funds for State and Local Health Departments, 
Universities, and Other Public and Private Agencies 
District of Columbia, 2000* 
Categories Dollars 
GRANTS/COOPERATIVE AGREEMENTS 
AIDS/HIV+ Programs 18,246,996 
Cancer Prevention 3,363,038 
Chronic Disease Prevention/Health Promotion 9,123,872 
Diabetes Control 532,338 
Environmental Health 2,459,349 
Immunization 6,055,875 
Infant Health/Pregnancy 631,791 
Infectious Diseases 2,180,190 
Injury 2,408,OOO 
Lead 609,589 
Lyme Disease 139,999 
Occupational Safety and Health 7,637,632 
Other 48,003,152 
Sexually Transmitted Diseases 2,405,OlO 
Tobacco 1,301,678 
Tuberculosis 1,017,024 
Preventive Health and Health Services Block Grant 1,141,173 
CONTRACTS 
Research 
Services 
Training 
398,000 
11,965,OOO 
368,000 
TOTAL 119,987,706 
*Federal Fiscal Year = October 1, 1999, through September 30, 2000. 
+Acquired im munodeficiency syndrome/human immunodeficiency virus. 
Source: Procurements and Grants Office, Office of Program Support, Office of the 
Director, CDC. 
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Selected Demographic Information 
District of Columbia and United States 
Population (1999) 
Population Density (1999) (persons/square mile) 
Median Age (1999) 
Percentage of Population 
Age 265 Years (1999) 
Age >85 Years (1999) 
Percentage of Population Male/Female (1999) 
Percentage of Population Below Poverty Level (1999) 
Percentage of School-Aged Children Below Poverty 
Level (1999) 
Percentage of Live Births to Females Aged lo-17 
Years (1998) 
Racial/Ethnic Distribution of Population (1999) 
Percentage White 
Percentage Black 
Percentage Asian/Pacific islander 
Percentage American Indian/Alaskan Native 
Percentage Hispanic 
Educational Attainment (1999) (Age 225 years) 
High school graduate or more 
Completed bachelor’s degree or more 
Number of Counties (1999) 
Number of Local Health Departments 
District of 
Columbia United States 
519,000 272,690,813 
8,238.l 77.1 
37.6 35.5 
13.9 12.7 
1.8 1.5 
46.8153.2 ’ 48.9151 .I
14.9 11.8 _ 
23.3 15.9 
6.5 4.6 
:;:z I 
82.4 
12.8 
3.1 4.0 
0.3 0.9 
7.4 11.5 
82.8 83.4 
42.1 i 25.2 
0 3,083 
1 2,930 
Source: Most data are from the Bureau of the Census and are available on the Internet at 
<http://www.census.gov>. Percentage of live births to females aged lo-17 years are from the National 
Vital Statistics System (NVSS) of CDC’s National Center for Health Statistics (NCHS), which derives its 
data from registrars in all 50 states, New York City, and the District of Columbia. Numbers of counties 
and local health departments are updated by state health officers. 
. 
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Local Health Departments 
by Jurisdiction 
District of Columbia, 2001 
A City health department 
0 No county health department 
Source: State health department. 
! xiv 
District of Columbia State Health Agency 
The state health agency in the District of Columbia is the Commission of Public Health and is a 
component of a superagency, the District of Columbia Department of Human Services. Its 
mission is to ensure equitable access to comprehensive, high-quality public health services for all 
residents and visitors and to monitor and improve their health status. 
All 50 states and the District of Columbia have state health agencies, which are responsible for 
administering public health services within their jurisdictions. These agencies coordinate and 
oversee departments at the local level, usually through one of two organizational structures - as 
a component of a superagency or as a freestanding, independent agency responsible directly to 
the governor or board of health. The organizational structure between the state health agency and 
local agencies typically follows one of the following models: a) centralized organizational 
control, in which local health departments function directly under the state’s authority and are 
operated by the state health agency or a board of health; b) decentralized organizational control, 
in which local governments directly operate local health departments with or without a board of 
health; c) mixed centralized and decentralized organizational control, whereby local health 
services can be provided by the state health agency, local governmental units, boards of health, or 
health departments in other jurisdictions; or d) shared organizational control, whereby local 
health departments are under the authority of the state health agency and the local government 
and board of health. 
For this publication, definitions of state health agencies were derived from the Profile of State 
and Territorial Public Health Systems: United States, 1990 (Atlanta, GA: US Department of 
Health and Human Services, Public Health Service, CDC; December 1991). This publication 
describes how public health services are organized and delivered at state and local levels, as well 
as how state and local components of the overall agency interact. This publication is intended as 
a reference for federal, state, and local public health officials and policymakers. More 
information is available on the Internet at the following address: 
<http://www.cdc.gov/phppo/inpho/profle/states.htm>. 
For more information, contact Ivan C.A. Walks, M.D., director, DC Department of Health, 825 N 
Capitol St., N.E., Suite 4400, Washington, DC 20002-4210; telephone (202) 442-5999; FAX 
(202) 442-4788; E-mail <iwalks@dchealth.com>. 
Mortality 
Leading Causes of Death 
Years of Potential Life Lost 
I 2 
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Leading Causes of Death by Race/Ethnicity 
District of Columbia and United States 
19964998 
Heart Disease 
T 
Hispanic Al/AN Black White All Races 
Cancer 
250 
200 
150 
Hispanic Al/AN Black A/PI White All Races 
0 District of Columbia 
m United States 
- Healthy People 2000 target . 
*Rate is based on ~20 deaths and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; A/PI = Asian/Pacific Islander. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
Leading Causes of Death by RacelEthnicity 
District of Columbia and United States 
1996-l 998 
Stroke 
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Hispanic Al/AN Black White All Races 
Chronic Obstructive Pulmonary Disease 
70 
60 
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40 
30 
Hispanic Al/AN Black A/PI 
n District of Columbia 
m United States 
White All Races 
- Healthy People 2000 target 
*Rate is based on ~20 deaths and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; A/PI = Asian/Pacific Islander. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
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Leading Causes of Death by Sex 
District of Columbia and United States 
1996-I 998 
Heart Disease 
Male Female 
Cancer 
Male Female 
0 District of Columbia 
m United States 
- Healthy People 2000 target 
. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
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Leading Causes of Death by Sex 
District of Columbia and United States 
1996-I 998 
Stroke 
Male Female 
Chronic Obstructive Pulmonary Disease 
70 
60 
50 
40 
30 
Male Female 
0 District of Columbia 
m United States 
- Healthy People 2000 target 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
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7 
Years of Potential Life Lost (YPLL) 
Before Age 75 Years: Leading Causes 
District of Columbia and United States, 1998 
2,400 
1,800 
1,600 
1,400 
1,200 
1,000 
800 
600 
400 
200 
0 
T 
- 
Cancer Heart Disease Injuries Suicide Homicide 
- 
- 
q District of Columbia 
n United States 
. 
Note: Injuries = Unintentional injuries. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
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Childhood Health Concerns 
Developmental Disabilities 
I Vaccination Coverage 
Infant Mortality 
Prenatal Care 
Birth Rates for Females Aged 1549 Years 
, 10 
Developmental Disabilities: 
Estimated Lifetime Costs 
for Children Born in District of Columbia, 1998 
Cerebral palsy 
P 
Hearing impairment 
Mental retardation e 
Vision impairment 
c 
0 10 20 30 40 50 60 70 80 90 100 
Cost in millions of dollars 
. 
Source: Division of Birth Defects, Child Development, and Disability and Health (proposed), 
National Center for Environmental Health, CDC 
I i 
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Vaccination Coverage with Measles and Other Vaccines 
Among Children Aged 19-35 Months 
District of Columbia and United States, 1999 
100 
80 
20 
0 I 
DTaP MMR Polio Hib Hepatitis B Varicella 
q District of Columbia 
1 United States 
Note: DTaP = Diphtheria and tetanus toxoids and acellular pertussis vaccine; MMR = 
Measles-mumps-rubella vaccine; Hib = Haemophilus influenzae type b vaccine; 
Varicella = Chickenpox vaccine; 4:3:1:3 = 4 DTaP, 3 Polio (inactivated polio vaccine), 
1 MMR, 3 Hib. 
Source: National Immunization Survey, CDC. 
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Infant Mortality: Leading Causes 
District of Columbia and United States 
1996-I 998 
Birth Defects 
l- * 
O> I 
Hispanic 
* 
I 
Al/AN 
I 
Black 
* 
I I 
White All Races 
Sudden Infant Death Syndrome (SIDS) 
‘- * 
0 
Hispanic 
* 
I 
Al/AN 
I 
Black 
* 
A/PI 
* 
I I 
White All Races 
Low BirthweightlRespiratory Distress Syndrome 
6- 
4- 
2- 
* * * * 
0 I I 
Hispanic Al/AN Black A/PI White All Races 
0 District of Columbia n United States 
. 
*Rate is based on ~20 deaths and is considered unreliable. 
Note: AI/AN = American Indian/Alaskan Native; Black = Black Non-Hispanic; 
A/PI = Asian/Pacific Islander; White = White Non-Hispanic. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
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Infant Mortality: Rates and Number of Deaths 
by RacelEthnicity 
District of Columbia and United States, 19964998 
20 
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Hispanic Al/AN Black A/PI White All Races 
- (331) 
n District of Columbia 
m United States 
- Healthy People 2000 target 
*Rate is based on ~20 deaths and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; Black = Black Non-Hispanic; 
A/PI = Asian/Pacific Islander; White = White Non-Hispanic. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
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Prenatal Care: Women Who Did Not Receive Prenatal Care 
During the First Trimester of Pregnancy by Race/Ethnicity 
District of Columbia and United States, 19964998 
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‘;;‘ b 
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n District of Columbia 
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- Healthy People 2000 target 
. 
*Rate is based on ~200 births and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; Black = Black Non-Hispanic; 
A/PI = Asian/Pacific Islander; White = White Non-Hispanic. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
Birth Rates for Females Aged 1549 Years 
by Race/Ethnicity 
District of Columbia and United States, 19964998 
180 
160 
20 
0 
Hispanic Al/AN Black A/PI White All Races 
- 
q District of Columbia 
n United States 
United States rate - 56.7 
*Rate is based on ~26 births or cl ,000 women and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; Black = Black Non-Hispanic; 
A/PI = Asian/Pacific Islander; White = White Non-Hispanic. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
Deaths from Injuries 
Motor Vehicle-Related Deaths 
Suicide 
Homicide 
18 , 
Motor Vehicle-Related Deaths 
1998 
CT 10.1 
DC 9.8 
DE 15.2 
MA 7.8 
MD 12.3 
NH 11.9 
NJ 9.2 
RI 8.7 
VT 13.3 
Age-adjusted death rates per 100,000 population 
17 7.8 - 12.7 q 12.8 - 17.1 17.2 - 21.1 w 21.2 - 34.3 
United States rate - 15.7; Healthy People 2000 target - 14.2 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
CT 
DC 
DE 
MA 
MD 
NH 
NJ 
RI 
VT 
Death rates per 100 million miles traveled 
q 0.8 - 1.2 q 1.3- 1.5 1.6 - 1.8 n 1.9-2.8 
United States rate - 1.6; Healthy People 2000 target - 1.5 
Source: Fatal Accident Reporting System, U.S. Department of Transportation. 
1.1 
1.6 
1.4 
0.8 
1.3 
1.1 
1.2 
0.9 
1.6 
E! 
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Suicide Rates, 1998 
CT 7.2 
DC 7.3 
DE 8.0 
MA 7.5 
MD 8.9 
NH 12.7 
NJ 6.4 
RI 8.1 
VT 12.8 
Age-adjusted death rates per 100,000 population 
0 6.4-9.3 q 9.4-11.2 11.3- 13.1 n 13.2 - 22.1 
United States rate - 10.4; Healthy People 2000 target - 10.5 
Suicide Rates 
District of Columbia and United States, 19964998 
15 1 
I I I I 
Hispanic AI/AN Black A/PI 
0 District of Columbia 
m United States 
White All Races 
. - Healthy People 2000 target 
*Rate is based on c20 deaths and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; A/PI = Asian/Pacific Islander. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
m - 
20 
Homicide Rates, 1998 
CT 5.0 
DC 44.6 
DE 3.9 
MA 2.3 
MD 12.3 
NJ 4.4 
RI 2.6 
Age-adjusted death rates per 100,000 population 
III 2.2 - - 3.9 q 4.0 - 6.5 6.6 - 9.2 n 9.3 44.6 
United States rate - 7.1; Healthy People 2000 target - 7.2 
Homicide Rates 
District of Columbia and United States, 19964998 
loo- 
go- 
80- 
70- 
60- 
50- 
40- 
30- 
20- 
- 110 , 
Hispanic AI/AN Black A/PI White All Races 
0 District of Columbia 
m United States 
. - Healthy People 2000 target 
*Rate is based on ~20 deaths and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; A/PI = Asian/Pacific Islander. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
m - 
Env-ironmental 
Health Concerns 
j Air Quality Standards 
Asthma 
Disabilities 
Childhood Lead Poisoning Prevention 
Air Quality Standards 
1998 
91.3 
0.0 
100.0 
37.5 
67.6 
2.8 
29.6 
0.0 
0.0 
HI 12.0 
c 
Percentage of persons living in counties not meeting 
US. Environmental Protection Agency air quality standards 
0 0.0% - 7.4% q 9.7% - 28.2% q 28.7% - 42.2% n 42.3% - 100.0% 
United States - 40.6% 
. 
Source: Aerometric Information Retrieval System, U.S. Environmental Protection Agency. 
m 
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Asthma: Projects Funded by CDC 
Fiscal Year 2000 
States with funded projects 
Note: Federal fiscal year 2000 = October 1, 1999, through September 30, 2000. 
Source: Air Pollution and Respiratory Health Branch, National Center 
for Environmental Health, CDC. 
24 
Disabilities Reported by Adults 
BRFSS, 1998 
Rates per 100 persons aged 218 years (%) 
States reporting BRFSS disability/quality-of-life data 
13.6 
14.2 
15.2 
. 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
Childhood Lead Poisoning Prevention 
Programs and Surveillance Grants 
Fiscal Year 2000 
q 38 state programs (including DC) n 3 surveillance grants 
0 16 city or county programs (including DC) 
0 1 
0 2 
0 3 
0 4 
0 5 
0 6 
0 7 
0 8 
Los Angeles County, CA 0 9 
San Diego County, CA 0 10 
Salt Lake City, UT C 11 
Houston, TX 0 1 
Harris County, TX c 3 
Detroit, Ml 0 4 
Marion County, IN 0 15 
Jefferson County, KY 0 16 
Pinellas County, FL 
Duval County, FL 
Washington, DC 
New York City, NY 
Westchester County, NY 
Boston, MA 
Miami, FL 
Memphis, TN 
Note: Federal fiscal year 2000 = October 1, 1999, through September 30, 2000. 
Source: Lead Poisoning Prevention Branch, National Center for Environmental Health, CDC. 
Occupational 
Health Concerns 
Occupational Lung Disease Mortality 
Traumatic Occupational Fatalities 
Occupational Illnesses 
28 
Occupational Lung Disease Deaths 
1987-l 996 
CT 4.0 
DC 2.1 
DE 13.8 
MA 4.7 
MD 8.6 
NH 4.6 
NJ 10.6 
RI 3.9 
VT 5.8 
Age-adjusted death rates per 1 million adults 
0 1.0-3.2 II 3.4 - 4.7 4.8 - 6.9 n 7.6 - 125.4 
United States rate - 9.4 
Occupational Lung 
District of Columbia 
I 
Disease Deaths by Condition 
and United States, 1987-I 996 
Asbestosis 
cvw7 
I 
Silicosis I 
Byssinosis 
Unspecified/Other- 
1 2 3 4 5 
Age-adjusted death rates per 1 million adults 
0 District of Columbia 
n United States 
Note: Adults = persons aged 215 years; CW P = Coal workers’ pneumoconiosis. 
Source: National Surveillance System for Pneumoconioses Mortality, CDC. 
E 
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Traumatic Occupational Fatalities 
by Cause of Death and Occupational Division 
District of Columbia and United States, 19914995 
Motor Vehicle 
Homicide 
* 
Falling Object-m 
Electrocution - 
* 
Suicide-m 
Air Transport- 
* 
* 
Nature/Environment 
Explosion -m * 
Other - 
0 5 
Percentage (%) 
Farm/Forest/Fishing 
Transport 
Laborers 
Crafts 
Tech/Support 
Machine Operation 
Sales 
Service 
I I I I I I I I I I I 
0 5 10 15 20 25 30 35 40 45 50 55 60 
ExeclAdmIMgr 
Professional/Specialist 
x 
. 
Rates per 100,000 workers 
q District of Columbia 
n United States 
*Fewer than 3 deaths in this category. 
Source: National Traumatic Occupational Fatalities Surveillance System, CDC. 
30 
Traumatic Occupational Fatalities: All Industries 
19914995 
CT 154 
DC 101 
DE 48 
MA 280 
MD 306 
NH 62 
NJ 439 
RI 59 
VT 51 
Number of deaths and average annual rates per 100,000 workers 
cl 1.9 - 3.1 0 3.4 - 4.7 5.0 - 6.4 n 6.7 - 21.3 
United States - 26,257 (rate - 4.3) 
Traumatic Occupational Fatalities: 
19914995 
Construction Industry 
CT 
DC 
DE 
MA 
MD 
NH 
NJ 
RI 
VT 
5.3 
25.6 
6.5 
9.0 
5.4 
7.4 
10.5 
10.0 
5.8 
Average annual rates per 100,000 workers 
q 4.7 - 9.6 -0 10.0 - 12.7 12.8 - 15.7 n 16.1 - 32.9 
United States rate - 12.2 
Source: National Traumatic Occupational Fatalities Surveillance System, CDC. 
I 
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Mining Industry 
* 
Traumatic Occupational Fatalities: 
19914995 
CT 
DC 
DE 
MA 
MD 
NH 
NJ 
RI 
VT 
* 
* 
* 
Average annual rates per 100,000 workers 
0 7.3 - 16.6 q 17.3 - 26.5 27.4 - 37.9 n 41.8 - 82.6 
United States rate - 24.3 
Traumatic Occupational Fatalities: Agriculture Industry 
19914995 
CT 14.8 
DC 82.0 
DE 11.1 
MA 17.8 
MD 14.9 
NH 6.3 
NJ 13.2 
RI 25.0 
VT 7.2 
Average annual rates per 100,000 workers 
cl * 6.3 - 13.2 q 13.8- 17.4 17.8 - 22.0 n 22.6 - 285.2 
*Not available. United States rate - 17.0 
Source: National Traumatic Occupational Fatalities Surveillance System, CDC. 
32 
Occupational Illnesses 
by Category of Illness and Industry Division 
District of Columbia* and United States, 1998 
Skin Disease - 
Dust Disease 
f 
c Respiratory Condition - 
z 
5 
z? Poisoning 
!$ 
z 
Physical Agent - 
Repeated Trauma - 
All Other - 
0 
I I I I 
5 10 15 20 25 30 
Incidence rates per 10,000 full-time workers 
Agriculture - 
Mining -- 
Construction -m 
s 
Mfg Durable Goods -L 
.- ul .- 
> Mfg Nondurable Goods .- 
-0 
2 
iYJ 
Transportation -m 
2 Wholesale Trade -w 
S 
Retail Trade -B 
Finance/Ins/Real Est 
Services - 
I I I I I 
I 
0 20 40 60 80 100 120 
140 
Incidence rates per 10,000 full-time workers 
. q District of Columbia 
n United States 
*Check Interpretation section for a list of states from which data is not available. 
Source: Survey of Occupational Injuries and Illnesses, Bureau of Labor Statistics. 
Infectious Diseases 
Acquired lmmunodeficiency Syndrome 
(AIDS) 
Malaria 
Chlamydia and Gonorrhea 
Primary and Secondary Syphilis 
Pneumonia and Influenza Deaths 
Lyme Disease 
Tuberculosis 
34 
Acquired lmmunodeficiency Syndrome (AIDS) 
Estimated Rates of Adults/Adolescents Living with AIDS 
December 1999 
212 
1,377 
178 
151 
228 
48 
217 
109 
35 
Rates per 100,000 population 
q 8 - 45 El 46 - 81 n 145 - 1,377 
United States rate - 141 (315,903 cases) 
Washington, DC rate - 268 (10,415 cases) 
. 
Source: HIV/AIDS Case Surveillance System, CDC. 
m! 
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Malaria: Reported Cases 
19904 999 
119 
92 
31 
387 
302 
28 
137 
20 
42 
cl 0 - 28 q 29 - 73 m 74 - 207 n > 208 
United States - 11,563 
Note: 1999 data are provisional. 
Locally Acquired, Mosquito-Transmitted 
Malaria Cases, 1985-I 
1 
3 
Number of cases 
Source: National Malaria Surveillance System, National Center for Infectious Diseases, CDC. 
36 
Chlamydia, 1999 
CT 227 
DE 371 
MA 143 
MD 264 
NH 82 
NJ 153 
RI 237 
VT 82 
Reported case rates per 100,000 population 
q 82- 186 0 187-234 235 - 276 n 277 - 482 
United States rate - 251 
Gonorrhea, 1999 
CT 101 
DE 224 
MA 40 
MD 203 
NH 10 
NJ 97 
RI 61 
VT 9 
HI 39 
Reported case rates per 100,000 population 
06-38 q 39-96 97 - 161 n 162-392 
United States rate - 131; Healthy People 2000 target - 100 
Source: National Center for HIV, STD, and TB Prevention, CDC, and state and territorial 
health departments and sexually transmitted disease control programs. 
QE 
37 
Primary and Secondary Syphilis 
1999 
Cl 0.0 - 0.2 
HI 0.3 
Reported case rates per 100,000 population 
q 0.3 - 0.7 
MA 
L NJ 
RI 
VT 
n 3.4 - 11.8 
United States rate - 2.5; Healthy People 2000 target - 4.0 
. 
0.5 
1.3 
0.6 
6.7 
0.1 
0.8 
0.3 
0.5 
Source: National Center for HIV, STD, and TB Prevention, CDC, and state and territorial 
health departnients and sexually transmitted disease control programs. 
38 
Pneumonia and Influenza: 
Number of Deaths, 1998 
CT 1,225 
DC 204 
DE 248 
MA 2,895 
MD 1,641 
NH 277 
NJ 2,356 
RI 382 
VT 237 
Number of deaths 
United States - 91,871 
Pneumonia and Influenza Death Rates by Race/Ethnicity 
District of Columbia and United States, 19964998 
30 
Hispanic AI/AN Black A/PI 
0 District of Columbia 
n United States 
White All Races 
*Rate is based on ~20 deaths and is considered unreliable. 
Note: Al/AN = American Indian/Alaskan Native; A/PI = Asian/Pacific Islander. 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
e 
39 
Lyme Disease: 
Reported Cases, 1999 
United States - 16,273 
. 
Note: 1 dot = 1 case randomly placed within county of residence. 
Source: National Electrcinic Telecommunications System for Surveillance, CDC. 
/ 40 
Tuberculosis: Case Rates, 1999 
CT 3.7 
DC 13.5 
DE 4.5 
MA 4.4 
MD 5.7 
NH 1.6 
NJ 7.0 
RI 5.3 
VT 0.5 
Reported case rates per 100,000 population 
0 0.5 - 2.3 q 2.4 - 4.4 4.5 - 7.0 n 7.1 - 15.5 
United States rate - 6.4: Healthy People 2000 target - 3.5 
Percentage of Tuberculosis Cases Among 
Foreign-Born Persons, 1999 
0 0% - 19% 0 20% - 32% 33% - 51 ‘xx n 52% - 77% 
United States - 43% 
Source: National Center for HIV, STD, and TB Prevention, CDC. 
Chronic Diseases: 
Conditions and Risk Factors 
Oral Health 
Prevalence of Diagnosed Diabetes 
Prevalence of Physical Inactivity 
and Ovetweight 
Total Cardiovascular Disease 
Breast Cancer and Mammography 
Colorectal Cancer and Proctoscopy 
Lung Cancer and Current Smoking 
Prevalence of Smoking 
. 
Prevalence of Health-Care Coverage 
t 
42 
Adults Aged 165 Years Who Have Lost All 
Natural Teeth, BRFSS, 1995-I 999 
Average prevalence (%) 
cl < 22% q 22%-25% m 26% -29% n >29% 
BRFSS median - 26%; Healthy People 2000 target - 20% 
Adults Aged 135 Years Who Have Visited a Dentist 
or Dental Clinic in the Last Year, BRFSS, 19954999 
79 
71 
71 
76 
72 
73 
74 
75 
72 
Average prevalence (%) 
cl < 65% q 65% - 67% 68%-71% n >71% 
BRFSS median - 69%; Healthy People 2000 target - 70% 
*Data not available. 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
m 
43 
Prevalence of Diagnosed Diabetes 
District of Columbia and BRFSS Median 
1997-I 999 
1 
. 
I 
45-64 
I 
65-74 
Age groups (years) 
0 District of Columbia 
n BRFSS median 
I 
Total 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
44 
Prevalence of Physical Inactivity During Leisure Time 
BRFSS, 1994,1996, and 1998 
25 
39 
36 
24 
28 
25 
30 
28 
24 
Average prevalence (“Y’o) 
cl < 24% q 24% - 28% n 29% - 36% n > 36% 
BRFSS median - 29%; Healthy People 2000 target - 15% 
Prevalence of Oveweight 
BRFSS, 1994,1996, and 1998 
CT 26 
DC 29 
DE 31 
MA 26 
MD 31 
F 
NH 26 
NJ 27 
RI 29 
VT 26 
Average prevalence (%) 
cl c 27% - q 27% - 29% n 30% - 32% n > 32% 
BRFSS median - 29%; Healthy People 2000 target - 20% 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
Total Cardiovascular Disease: Deaths, 1998 
CT 146 
DC 205 
DE 161 
MA 135 
MD 159 
NH 146 
NJ 152 
RI 145 
VT 138 
Age-adjusted death rates per 100,000 population 
cl 118- 138 c] 139-151 152 - 176 n 177-227 
United States rate - 162 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
Total Cardiovascular Disease: Behavioral Risk Factors 
District of Columbia and BRFSS Median, 1998 
80 
70 
g 60 
3 50 
E 
al 40 
B 
d 30 
20 
10 
0 
Smoking Overweight <5 Fruits/Vegetables Physically Inactive 
0 District of Columbia 
BRFSS median 
n Healthy People 2000 target 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
! 46 
Breast Cancer: Deaths Among Women 
District of Columbia and United States, 1988-1998 
35- 
30- 
25- 
w - 
20- - - 
w 0 
15- 
10- 
5- 
0 I I I I I I I I I I I 
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 
+ District of Columbia 
-f- United States 
- Healthy People 2000 target 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
Women Aged F50 Years Who Have Had a Clinical 
Breast Exam and a Mammogram Within 2 Years 
District of Columbia and BRFSS Median, 1994-I 999 
100 , 
I 
90 
80 
fi T 
1996 1997 
I I 
1998 1999 
I 0 District of Columbia 
m BRFSS median 
*Not available 
- Healthy People 2000 target 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
. s 
47 
Colorectal Cancer: Deaths 
District of Columbia, 1988-I 998 
25 
0 I I I I I I I I I I I 
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 
+ Male --t Total 
-o- Female - Healthy People 2000 target 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
Adults Aged 150 Years Who Reported Having a Sigmoidoscopy 
District of Columbia and BRFSS Median, 1995, 1997, and 
50 
40 
?+ e 
& 30 
B iz 
8 G 20 
a 
10 
0 L * 
- -. 
U Drstnct of Columbia 
m BRFSS median 
- Healthy People 2000 target 
*Not available 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
48 
100 
go- 
Lung Cancer: Deaths 
District of Columbia, 1988-I 998 
-0 8K 80- 
s ‘Z 
cl 
55 
70- 
88 60- 
UQ 
u" aI0 50- 
lz 0 
.20 
00 
40- 
Lp: aal 30- 
rnQ 
a 20- 
10 
1 
0’ , I I I I I I I I I. I 
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 
,-t- Male --t Total 
+ Female - Healthy People 2000 target 
Source: National Vital Statistics System, National Center for Health Statistics, CDC. 
Current Cigarette Smoking Among Adults 
District of Columbia, 1995-I 999 
T 
: 
* 
Pi995 1996 1997 1998 
*Not available. 
m Male m Total 
Female - Healthy People 2000 target 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
m 
49 
50 
‘40 
Prevalence of Smoking 
Among Selected Demographic Groups 
District of Columbia and BRFSS Median, 1999 
- 
* * * 
I I I I I I I 
I I I I I I I 
Hispanic Black HS Ed or Less Total 
AI/AN A/PI Women 18-44 
Demographics 
0 District of Columbia 
m BRFSS median 
- Healthy People 2000 target 
. 
*Data not available. 
Note: Data not available from all states for all racial/ethnic groups for median calculation. 
Al/AN = American Indian/Alaskan Native; A/PI = Asian/Pacific Islander. 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
50 
Prevalence of Not Having Health-Care Coverage 
for Adults Aged 18-64 Years 
District of Columbia and BRFSS Median, 1999 
60 
50 
10 
* * 
I 
Hispanic Al/AN Black A/PI White All Races 
District of Columbia 
BRFSS median 
. 
*Not available. 
Note: Al/AN = American Indian/Alaskan Native; A/PI = Asian/Pacific Islander. 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
Health Promotion 
Strategies 
Training Networks 
Adult Vaccination Coverage 
8 
52 
Public Health Training Network (PHTN) 
Fiscal Year 2000 
545 
108 
221 
280 
1026 
357 
383 
118 
84 
Number of registered health professionals receiving training through PHTN 
cl 84 - 280 cl 293 - 471 I 512 - 1,056 1,071 - 3,443 
United States - 38,720 
National Laboratory Training Network (NLTN) 
July 1999-June 2000 
VT 56 
Number of health professionals receiving training through NLTN 
0 11 -36 q 39 - 67 I 70 - 92 n 110-652 
United States - 4,782 
Note: Federal fiscal year 2000 = October 1, 1999, through September 30,200O. 
Source: Public Health Practice Program Office, CDC. 
H! 
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Adult Vaccination Coverage for Influenza, 1999 
Adult Vaccination Coverage for Pneumococca 
CT 49 
DC 35 
DE 67 
MA 57 
MD 54 
NH 60 
NJ 55 
RI 57 
VT 57 
HI 56 
CT 65 
DC 56 
DE 68 
MA 69 
MD 63 
NH 65 
NJ 65 
RI 76 
VT 73 
- HI 74 
c’ 
Vaccination coverage among persons aged 265 years (%) 
0 5 64% [rl 65% - 67% 60% - 70% W>71% 
BRFSS median - 67%; Healthy People 2000 target - 60% 
Vaccination coverage among persons aged 265 years (%) 
0 150% - q 51% - 54% I 55% - 56% n L57% 
BRFSS median - 54%; Healthy People 2000 target - 60% 
Source: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
m - 
Interpretation 
Interpretation 
INTRODUCTORY MATERIAL 
Information in the annual State Health Profile publication series was obtained from data files or 
published reports of several governmental and nongovernmental agencies and organizations. In 
each case, the sponsoring agency or organization collected data using its own methods and 
procedures. Therefore, the data in this publication varies in terms of source, method of collection, 
definitions, and reference period. 
Much of the information in this publication is from the ongoing data collection systems of 
CDC’s National Center for Health Statistics (NCHS). An overview of these systems can be found 
in Vital & Health Statistics (1989;23:1-21). Data sometimes differ from those published by the 
states because a) the cut-off dates for accepting vital statistics records into the annual file for 
producing statistics can be different and b) the interstate exchange program through which states 
receive data on events that involved residents but occurred in other states might not include all 
records. 
Electronic files of all data on which the graphic presentations in this publication are based are 
available on the Internet at the NCHS Data Warehouse, located at <http://www.cdc.gov/nchs/ 
datawh.htm>. 
Health Status Indicators 
The Public Health Service’s publication 
Healthy People 2000: National Health Pro- 
motion and Disease Prevention Objectives 
establishes a framework for developing an 
explicit national prevention program (199 1; 
DHHS publication no. [PHS]91-50212). As 
part of this program, a consensus set of 18 
health status indicators was developed to 
help communities assess their general health 
status and focus local, state, and national 
efforts on tracking year 2000 objectives. 
These indicators were chosen, in part, based 
on whether relevant data were readily avail- 
able and commonly used in public health. 
The 18 health status indicators were devel- 
oped by a committee through a consensus 
process involving local, state, and federal 
health officials and representatives from 
academic institutions and professional asso- 
ciations (MMWR 1991;40:449-5 1). These 
indicators are intended to ensure data com- 
parability and facilitate use by public health 
agencies at all levels of government. They 
are not intended to supersede specific mea- 
sures suggested in Healthy People 2000, but 
to give an indication of a community’s gen- 
eral health status. 
Bioterrorism 
In 1999, CDC was designated by the U.S. 
Department of Health and Human Services 
(DHHS) to coordinate and lead overall plan- 
ning to upgrade national public health capa- 
bilities at the federal, state, and local levels 
to respond to bioterrorism, which is the de- 
liberate use of biological agents to harm 
civilians. CDC’s program also addresses 
chemical terrorism, including plans to en- 
hance laboratory capabilities and medical 
stockpiles. Building an effective and flexible 
public health infrastructure is the best de- 
fense against disease outbreaks, whether 
natural or intentional. Tools developed to 
respond to bioterrorist events also can be 
used to improve the recognition and control 
of other emerging disease threats. 
58 
During fiscal year (FY) 1999 and 2000, 
CDC awarded approximately $80 million to 
55 state, territorial, and major metropolitan 
health departments to develop and maintain 
core capacity for five primary components of 
bioterrorism preparedness and response. 
These components are preparedness plan- 
ning and readiness assessment, epidemiol- 
ogy/surveillance capacity, laboratory capac- 
ity for biologic agents, laboratory capacity 
for chemical agents, and communications/ 
training. CDC’s funding will help states and 
cities upgrade their capabilities in these ar- 
eas and link their activities with other local, 
state, and federal emergency plans. 
Preparedness Planning 
and Readiness Assessment 
State and local public health communities 
will bear much of the responsibility for ad- 
dressing the health aspects of a bioterrorist 
attack. State and local officials will be called 
upon to quickly evaluate a potential threat, 
identify public health response and preven- 
tion strategies, advise the public on protec- 
tive actions, and outline procedures for first 
responders and health-care providers. 
During the past year, CDC has conducted 
several projects in this area, including: 
. Providing on-site support for the World 
Trade Organization meeting in Seattle, 
Republican National Convention in Phil- 
adelphia, Democratic National Conven- 
tion in Los Angeles, and a West Nile 
encephalitis outbreak in New York City. 
CDC staff members helped identify 
causative agents, conduct epidemiologic 
investigations, and enhance existing sur- 
veillance systems to detect illness. 
l Completing preliminary bioterrorism 
preparedness guidelines for hospitals, 
addressing topics such as mass casualty 
procedures, triage considerations, decon- 
tamination issues, and epidemiologic 
and detection recommendations. 
l Developing curricula on clinical mani- 
festations and treatments of illnesses 
caused by organisms and toxins on 
CDC’s critical agents list. 
l Completing and evaluating CDC’s role 
in at least four simulated response exer- 
cises. 
State/local projects include: 
l Establishing three Exemplar Centers for 
Public Health Preparedness in Colorado 
(Denver City and County), Georgia 
(DeKalb County), and New York (Mon- 
roe County). 
Epidemiology/Surveillance Capacity 
CDC is working with state and local partners 
to ensure that local epidemiologic and sur- 
veillance capacities are established or en- 
hanced across the nation. If health-care pro- 
viders can detect unusual events early (e.g., 
injuries caused by chemical agents or dis- 
ease outbreaks caused by pathogens likely to 
be used by terrorists), potential victims can 
receive appropriate medical treatment or be 
protected with prophylactic medicines or 
vaccines. 
During the past year, CDC has conducted 
several projects in this area, including: 
l Creating or updating case definitions for 
diseases or conditions caused by critical 
threat agents. 
l Developing standard bioterrorism curric- 
ula and associated training materials. 
State/local projects include: 
l Developing a Rapid Syndrome Report- 
ing System in New Mexico that allows 
physicians to quickly report symptoms 
(e.g., flu-like symptoms and fever with 
altered mental status) using a unique 
touch screen computer that is being 
pilot-tested in selected emergency de- 
partments. 
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. Initiating a web-based reporting system 
in New York that allows real-time data- 
gathering for disease surveillance. The 
state also is exploring using hospital 
claims data to detect bioterrorist events 
early. 
Developing MERLIN, a web-based dis- 
ease reporting system in Florida that will 
allow the state health department o con- 
duct mortality surveillance for 
unexplained and unusual deaths and 
electronic death certificate review. 
Laboratory Capacity for Biologic 
and Chemical Agents 
Rapid identification of a bioterrorist agent 
will be critical to ensuring that prevention 
and treatment recommendations are imple- 
mented quickly. CDC is working with state 
and local partners to enhance the country’s 
current public health laboratory capacity to 
identify pathogens likely to be used for bio- 
terrorism. 
Major components of this effort include a) 
enhancing local ability to identify biologic 
and chemical agents likely to be used for 
bioterrorism; b) creating a rapid response 
and advanced technology laboratory capable 
of supporting local and state health depart- 
ments and bioterrorism response teams 24 
hours a day; and c) working with public 
health partners to build on the existing labo- 
ratory infrastructure to develop a multilevel 
network of laboratories with state-of-the-art 
capabilities for detecting a range of biologi- 
cal threats. 
Laboratories are categorized according to 
their level of safety and containment stan- 
dards. Level A laboratories are public health 
and hospital laboratories with low-level bio- 
safety facilities that use clinical data and 
standard microbiological tests to decide 
which specimens and isolates should be for- 
warded to higher level biocontainment labo- 
ratories. Level B laboratories are state and 
local public health agency laboratories with 
core capacity for agent isolation and 
presumptive-level testing of suspect speci- 
mens. Level C laboratories can perform ad- 
vanced and specialized testing, and they can 
be located at state health agencies, academic 
research centers, or federal facilities. 
During the past year, CDC has conducted 
several projects in this area, including: 
l Developing curricula on clinical mani- 
festations and treatments of illnesses 
caused by organisms and toxins on 
CDC’s critical agents list. 
State/local projects include: 
l Initiating electronic laboratory reporting 
in California for Level A, B, and C labo- 
ratories, which will allow rapid commu- 
nication of laboratory results in the event 
of a suspected bioterrorist event. 
l Modifying Iowa’s state public health lab- 
oratory (the University Hygienic Labora- 
tory) so it can serve as a conIirmatory 
laboratory for suspected bioterrorism 
events in Iowa and other states needing 
Level B or C confirmation. 
Communications/Training 
CDC is working with state and local health 
departments to establish the Health Alert 
Network (HAN) for communications, infor- 
mation, and training related to bioterrorism. 
HAN is a nationwide, integrated system con- 
necting the nation’s state and local health 
departments through the Internet. This net- 
work will serve as the common electronic 
platform for national disease surveillance, 
epidemiologic investigation, electronic labo- 
ratory reporting, and rapid communications. 
When fully implemented with grants to state 
and local health departments, HAN will link 
local, state, and federal public health agen- 
cies and partners and will be used to protect 
communities against a range of public health 
threats. 
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During the past year, CDC has conducted 
several projects in this area, including: 
l Developing and maintaining CDC’s pub- 
lic website for nonsensitive bioterrorism 
information, which is available at 
<http.//www.bt.cdc.gov>. 
l Funding 40 state and local areas for in- 
formation systems projects related to 
bioterrorism, targeting three focus areas 
- Internet connectivity, distance- 
based-learning capacity, and broadcast 
communications capacity. 
l Teaching eight Level A laboratory 
preparedness courses to approximately 
700 professionals through joint training 
efforts by CDC, the FBI, and faculty 
members in selected states. 
State/local projects include: 
l ‘Conducting information systems training 
and establishing Internet service in 27 
local health departments in Connecticut. 
l Connecting one private and one public 
hospital to Delaware’s satellite-based 
training network. Delaware plans to con- 
nect all hospitals in the state by the end 
of the 3-year project period. 
l Using HAN in Minnesota to report pos- 
sible exposure of persons to asbestos 
containing vermiculite, then to provide 
rapid information from the state health 
department o the public, health-care 
providers, and others throughout the 
state. 
l Conducting needs assessments of exist- 
ing technology capacity at 12 local 
health offices in New Hampshire. Also 
providing training on the Internet, the 
state’s Distance Learning Network, and 
online national and state information 
related to bioterrorism. 
9 Conducting three bioterrorism awareness 
training sessions via satellite for health 
and local government officials in Rhode 
Island. 
l Establishing broadcast fax capability that 
allowed health officials in Vermont to 
rapidly inform local health departments 
about a hantavirus case in April 2000. Infor- 
mation distributed included CD0 website 
and locally generated response guidance. 
National Pharmaceutical 
Stockpile Program 
In addition to coordinating the overall public 
health response to bioterrorist events, CDC 
is mandated to develop and maintain the 
National Pharmaceutical Stockpile Program 
(NPSP). This program is being developed 
with DHHS’s Office of Emergency Pre- 
paredness. In the event of a bioterrorism 
emergency, the federal government will use 
NPSP to give states rapid access to neces- 
sary vaccines, antitoxins, therapeutic drugs, 
and antidotes. 
During the past year, CDC has conducted 
several projects in this area, including: 
l Negotiating successfully with the 
Veteran’s Administration to establish 
vendor-managed contracts that will al- 
low NPSP to obtain, rotate, and rapidly 
deploy appropriate items after a bio- 
terrorist event. 
l Conducting a full field exercise to test 
readiness and distribution capabilities at 
the state and local level. 
l Designing a delivery and distribution 
system for 12-hour push packages, 
which are caches of medical material 
(e.g., vaccines, antidotes, respirators, and 
bandages) necessary to treat patients ex- 
posed to biological or chemical agents. 
Push packages are located strategically 
throughout the United States and can be 
deployed within 12 hours of being re- 
quested. 
For more information, contact Cyndi Shaffer 
by telephone at (404) 639-013 1, by FAX at 
(404) 639-0382, or by E-mail at 
<csw3@cdc.gov>. 
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CDC Funds for States 
This section lists financial assistance pro- 
vided to and within states during FY 2000. 
Unobligated balances carried forward from 
previous years are not included. Most funds 
are provided to state and local health depart- 
ments and to special university-based pro- 
jects. In some cases, funds go to other state 
and nongovernmental agencies (e.g., state 
departments of education or community- 
based organizations for human immunodefi- 
ciency virus [HIV] and acquired immunode- 
ficiency syndrome [AIDS] programs). 
provide the information needed to develop 
state maps of the numbers and types of local 
health departments. In states where no such 
position exists, other state officials are asked 
to provide or confirm the necessary informa- 
tion. This report uses the following defini- 
tion of a local health department: “an admin- 
istrative and service unit of local or state 
government, concerned with health, employ- 
ing at least one full-time person, and carry- 
ing some responsibility for health of a juris- 
diction smaller than the state” (Am J Public 
Health 1977;67:93 l-9). 
Local Health Departments For more information, contact Ed Vaughn 
by Jurisdiction by telephone at 770-488-2430 or by FAX at 
In most states, local health liaison officials 770-488-8300. 
MORTALITY 
For data presented by race/ethnic&y, persons of Hispanic origin can be of any race. Conversely, 
persons listed as white, black, American Indian/Alaskan Native, or Asian/Pacific Islander can be 
of Hispanic or non-Hispanic origin. 
Numbers of deaths (numerators for death rates) are provided by the National Vital Statistics 
System (NVSS) of CDC’s National Center for Health Statistics (NCHS). Data are derived from 
information provided by registrars in all 50 states, New York City, and the District of Columbia. 
These data sometimes differ from those published by the states because a) the cut-off dates for 
accepting vital statistics records into the annual file for producing statistics can be different; b) 
the interstate xchange program through which states receive data on events that involved 
residents but occurred in other states might not include all records; and c) the international rules 
for selecting the underlying cause of death is interpreted and applied differently in some states. 
Population data (denominators for average annual death rates for 1996-l 998) are 1997 post- 
censal population estimates from the Bureau of the Census. Age and race data have been 
modified to be consistent with Office of Management and Budget categories and historical 
categories for birth data. These modification procedures are described in a report from the 
Bureau of the Census (Age, sex, race, and Hispanic origin informationfiom the 1990 census: a 
comparison of census results with results where age and race have been modified. 1990. 1991; 
CPH-L-74). Race and Hispanic origin data are self-reported or reported by a household member. 
Death rates are age-adjusted by the direct method to the 1940 U.S. population using the standard 
million age distribution in 11 age groups (see Table, page 62). Direct age-adjustment is calcu- 
lated by weighting the annual-age-specific rates by the population distribution in the standard 
population. 
For more information, contact Insun Kim, Dr.P.H., by telephone at (301) 458-43 13 or by FAX at 
(301) 458-4036. 
TABLE. Standard million age distribu- 
tion used to age-adjust death rates 
All ages 1 ,ooo,ooo 
<l year 15,343 
l-4 years 64,718 
5-14 years 170,355 
15-24 years 181,677 
25-34 years 162,066 
35-44 years 139,237 
45-54 years 117,811 
55-64 years 80,294 
65-74 years 48,426 
75-84 years 17,303 
285 years 2,770 
Leading Causes of Death 
Death rates are presented for several leading 
causes of death. Data are average annual 
age-adjusted eath rates for 1996-l 998 for 
men and women and for persons in the fol- 
lowing race/ethnicity categories: white, 
black, Hispanic, American Indian/Alaskan 
Native, and Asian/Pacific Islander. Race and 
Hispanic origin are recorded on death certifi- 
cates by funeral directors on the basis of 
information provided by the next of kin. 
In this section, death rates for race/ethnicity 
are presented for states that meet one of the 
following criteria: a) at least 150,000 popu- 
lation in the designated group in 1997 or b) 
at least 100 deaths from the specified cause 
of death among members of the designated 
group during 1996-l 998. Death rates based 
on ~20 deaths during 1996-l 998 are not 
shown. Data for persons of Hispanic origin 
are limited to the District of Columbia and 
the 49 states that reported Hispanic origin of 
decedent on death certificates and in which 
reporting was at least 80 percent complete 
for 1996-l 998. Data for Oklahoma are not 
available because that state did not record 
Hispanic origin of decedent on death in . 
1996. 
Data in this section are for the four leading Data in this section are for the five leading 
causes of death in the United States in 1997 causes of YPLL in the United States in 
according to the International Classification 
of Diseases, 9th Revision (hereafter eferred 
to as ICD-9): heart disease (ED-9 codes 
390-398,402,404-429), cancer (ED-9 
codes 140-208), stroke (ICD-9 codes 430- 
438), and chronic obstructive pulmonary 
diseases (ICD-9 codes 490496). Leading 
causes of death are defined as those causing 
the greatest number of deaths in the United 
States. They are not necessarily the leading 
causes of death for specific states or specific 
racial/ethnic or sex groups. 
Years of Potential Life Lost 
Years of potential life lost (YPLL) is a mea- 
sure of premature mortality, defined as the 
number of years between the age at death 
(for those who die before age 75 years) and 
age 75 years, YPLL is calculated from birth 
to age 75 years using the 1940 U.S. popula- 
tion and the following eight age groups: ~1 
year, l-14,15-24,25-34,35-44,45-54, 
55-64, and 65-74. The number of deaths for 
each age group is multiplied by the years of 
life lost, which is calculated as the differ- 
ence between age 75 years and the midpoint 
of the age group. For example, the death of a 
person in the 15-24 group counts as 55.5 
years of life lost. The total YPLL is all of the 
years of life lost over all age groups. 
Data in this section are race/ethnicity-spe- 
cific, age-adjusted YPLL per 100,000 popu- 
lation aged ~75 years for 1996-1998. Num- 
bers of deaths (numerators for YPLL rates) 
are from the NVSS. Population data (de- 
nominators for YPLL rates) are 1997 
postcensal population estimates from the 
Bureau of the Census. YPLL rates are age- 
adjusted by the direct method to the 1940 
U.S. population using the eight age groups 
cited previously. YPLL rates based on ~20 
deaths are not shown. Data for Oklahoma 
are not available because that state did not 
record Hispanic origin of decedent on death 
certificates in 1996. 
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1998: heart disease (ZCD-9 codes 390-398, 
402,404-429), cancer (ICD-9 codes 140- 
208), unintentional injuries (ICD-9 codes 
E800-E949), suicide (ICD-9 codes 
E950-E959), and homicide (ICD-9 codes 
E960- E969). They are not necessarily the 
leading causes of YPLL for specific states. 
Unintentional injuries include subcategories 
such as falls, drownings, fires/burns, poison- 
ings, and motor vehicle injuries. 
For more information on how to calculate 
YPLL, consult the Journal of Preventive 
Medicine (1988;4:268-73). 
CHILDHOOD HEALTH CONCERNS 
For the sections on Prenatal Care and Birth Rates for Females Aged 15-l 9 Years, data are from 
the National Vital Statistics System (l’WSS> of CDC’s National Center of Health Statistics 
(NCHS). Data are derived from information provided by registrars in all 50 states, New York 
City, and the District of Columbia. These data sometimes differ from those published by the 
states because a) the cut-off dates for accepting vital statistics records into the annual file for 
producing statistics can be different and b) the interstate xchange program through which states 
receive data on events that involved residents but occurred in other states might not include all 
records. Also, different organizations sometimes tabulate the race of the mother differently. For 
example, when the mother’s race is not reported but the father’s is, NCHS assigns the race of the 
father to the mother. When neither parent’s race is reported, the race of the mother is listed the 
same as the immediately preceding record that did have the race of the mother specified. This 
listing was necessary for ~1% of births during 1996-1998. 
Developmental Disabilities 
The total lifetime cost of a specific develop- 
mental disability for a given state (in 1996 
U.S. dollars) is calculated using the follow- 
ing formula: the prevalence rate of the de- 
velopmental disability multiplied by the 
number of 1998 live births in a given state 
multiplied by the per-person lifetime cost 
estimate associated with the developmental 
disability, based on a 3% discount rate. 
Sample estimates of the per-person lifetime 
costs of specific developmental disabilities 
include $797,592 for mental retardation, 
$706,704 for cerebral palsy, $275,7 17 for 
hearing impairment, and $386,074 for vision 
impairment (The Cost of Developmental 
Disabilities. Research Triangle Park, N.C.: 
Research Triangle Institute, April 2000). 
Mental retardation is defined as an intelli- 
gence quotient (IQ) of 170. Hearing impair- 
ment is defined as a measured, bilateral, 
pure-tone hearing loss at frequencies of 500, 
1,000, and 2,000 hertz averaging 240 deci- 
bels, unaided, in the better ear. Vision im- 
pairment is defined as a measured visual 
acuity of <20/70, with correction, in the 
better eye. Cerebral palsy is defined as a 
group of nonprogressive but often changing 
motor impairment syndromes secondary to 
lesions or anomalies of the brain arising at 
any time during brain development. 
Per-person lifetime cost estimates are based 
on a cost-of-illness approach that measures 
the value of all resources used or lost be- 
cause of a disability (excluding home care 
costs). Resource categories analyzed 
included physician office services, prescrip- 
tion medications, hospital inpatient services, 
therapy and rehabilitation services, long- 
term-care services, home and auto modifica- 
tions, special education services, and pro- 
ductivity losses resulting from increased 
illness and premature mortality. 
The number of live births in each state for 
1998 is reported from NCHS (Nat1 Vital Stat 
Rep 2000;48[3]). The average annual preva- 
I 
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lence rates of specific developmental dis- 
abilities among 1,000 children aged 5-l 0 
years during 1991-1994 were mental retar- 
dation, 11.29; cerebral palsy, 2.97; hearing 
impairment, 1.2 1; and vision impairment, 
1.02. These data came from CDC’s Metro- 
politan Atlanta Developmental Disabilities 
Surveillance Program. More information 
regarding birth and developmental disability 
rates is available on the Internet at 
<http://www.cdc.gov.nchs/dataf 
nvs48_3 .pdf>. 
For more information, contact Marshalyn 
Yeargin-Allsopp, M.D., by telephone at 
(770) 488-7400. 
Vaccination Coverage 
Data in this section are from the National 
Immunization Survey (NIS) and include 
immunization coverage rate:. For the follow- 
ing vaccines: a) four doses of diphtheria and 
tetanus toxoids and acellular pertussis vac- 
cine (DTaP); b) three doses of poliovirus 
vaccine; c) one dose of mecrles-mumps- 
rubella vaccine (MMR); d) three doses of 
Haemophilus injluenzae type b vaccine 
(Hib); e) three doses of hepatitis B vaccine 
(HepB); f) one dose of varicella (chicken- 
pox); and g) a 4:3: 1:3 combined series that 
includes four doses of DTaP, three doses of 
polio vaccine, one dose of MMR (or other 
measles-containing vaccine,) and three doses 
of Hib for children aged 19-35 months. 
The NIS is an ongoing survey conducted by 
CDC’s National Immunization Program that 
provides estimates of immunization cover- 
age for children aged 19-35 months for the 
United States as a whole, each of the 50 
states, and selected urban areas. CDC imple- 
mented the NIS in April 1994 as part of the 
Childhood Immunization Initiative, a na- 
tional strategy to achieve and maintain high 
immunization coverage in all 50 states, the 
District of Columbia, and 27 urban areas 
considered at high risk for undervaccination. 
For more information, contact Wayne 
Stevens by telephone at (404) 639-8730 or 
by FAX at (404) 639-8613. 
Infant Mortality 
To provide race/ethnicity data on infant mor- 
tality, the linked files of births and infant 
deaths for 1996-1998 were used for racial/ 
ethnic groups relevant to particular states. 
The national linked files of live births and 
infant deaths include vital records for infants 
who were born in a given year and died that 
same year or in the next year before their 
first birthday. Using linked files avoids dis- 
crepancies in the reporting of race between 
birth records and death certificates. 
Although discrepancies are relatively rare 
for white and black infants, they can be sub- 
stantial for other races. 
Data are provided for three leading causes of 
infant death for the three largest racial/ethnic 
groups for each state. For some states, data 
for fewer than three racial/ethnic groups are 
used because of the limited numbers of 
deaths. Rates based on ~20 deaths are con- 
sidered statistically unreliable, and caution 
should be used when comparing or interpret- 
ing such rates. 
The underlying cause of death is identified 
by ICD-9 code and ranked according to the 
three overall leading causes of death among 
infants in the United States: birth defects 
(ED-9 codes 740-759), low birthweight 
and prematurity (ICD-9 code 765) combined 
with respiratory distress syndrome (ICD-9 
code 769), and sudden infant death 
syndrome (SIDS) (ICD-9 code 798). 
The rate of SIDS has declined sharply since 
1989. Data for 1995 indicate that the SIDS 
rate declined 18.3% from 1994, representing 
the largest annual percentage decline since 
1983. This downward trend could reflect 
changes in the prevalence of known risk 
factors or changes in the diagnosis of SIDS. 
A strong association between SIDS and a 
prone sleeping position for infants has been 
established, and in 1992, the American 
Academy of Pediatrics began recommending 
that parents place infants on their backs or 
sides to sleep. 
For more information, contact Michele 
Lynberg by telephone at (770) 488-7180. 
Prenatal Care 
Data in this section are the average annual 
percentages of women who did not receive 
prenatal care during the first trimester of 
pregnancy during 1996-1998. The data are 
reported according to the following race/ 
ethnicity categories: white non-Hispanic, 
black non-Hispanic, Hispanic, American 
Indian/Alaskan Native, and Asian/Pacific 
Islander. Persons of Hispanic origin can be 
of any race. Percentages for racial/ethnic 
groups are provided for states with 2200 
births among mothers of the designated 
group during 1996-l 998. 
For more information, contact Insun Kim, 
Dr.P.H., by telephone at (301) 458-43 13 or 
by FAX at (301) 458-4036. 
Birth Rates for Females 
Aged 15-19 Years 
Birth rates for females aged 15-l 9 years are 
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the number of live births per 1,000 women 
aged 15-l 9 years in specified racial/ethnic 
groups that reside in each state. Data are 
average annual rates during 1996-1998 in 
the following groups: white non-Hispanic, 
black non-Hispanic, Hispanic, American 
Indian/Alaskan Native, and Asian/Pacific 
Islander. Rates have not been computed 
within states for racial/ethnic groups with 
~20 births to women or with ~1 ,000 women 
aged 15-l 9 years. 
Hispanic origin of the mother is reported 
separately on birth certificates and in the 
national census. For the 1% of records with 
no origin reported, the mother is assumed to 
be non-Hispanic, which means the reported 
rates for Hispanic women might be under- 
reported by this amount. Persons of Hispanic 
origin can be of any race. 
Population data (denominators for birth 
rates) are 1997 postcensal population esti- 
mates from the Bureau of the Census, modi- 
fied to be consistent with Office of Manage- 
ment and Budget categories and historical 
categories for birth data. 
For more information, contact Insun Kim, 
Dr.P.H., by telephone at (301) 458-43 13 or 
by FAX at (301) 458-4036. 
DEATHS FROM INJURIES 
Data in this section are a) age-adjusted eath rates for 1998 for motor vehicle-related deaths, 
suicide, and homicide and b) race/ethnicity-specific, average annual age-adjusted eath rates for 
1996-1998 for suicide and homicide. They are age-adjusted by the direct method to the 1940 
U.S. population using the standard million age distribution (see Table, page 62). Direct age- 
adjustment is calculated by weighting the annual age-specific rates by the population distribution 
in the standard population. 
Numbers of deaths (numerators for death rates) are provided by the National Vital Statistics 
System (NVSS) of CDC’s National Center for Health Statistics (NCHS). Data are derived from 
information provided by registrars in all 50 states, New York City, and the District of Columbia 
(except in Alaska, where the number of suicides are state data). These data sometimes differ from 
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those published by the states because a) the cut-off dates for accepting vital statistics records into 
the annual file for producing statistics can be different; b) the interstate xchange program 
through which states receive data on events that involved residents but occurred in other states 
might not include all records; and c) the international rules for selecting the underlying cause of 
death is interpreted and applied differently in some states. 
Population data (denominators for annual death rates) are from 1998 postcensal population 
estimates from- the Bureau of the Census. Estimates for 1997 were used for race/ethnicity- 
specific, average annual age-adjusted eath rates for 1996-1998 for suicide and homicide. Age 
and race data have been modified to be consistent with Office of Management and Budget 
categories and historical categories for birth data. These modification procedures are described in 
a report from the Bureau of the Census (Age, sex, race, and Hispanic origin informationfiom the 
1990 census: a comparison of census results with results where age and race have been 
modiJed. 1990. 199 1; CPH-L-74.). Race and Hispanic origin data are self-reported or reported by 
a household member. 
Death rates for suicide and homicide are presented by race/ethnicity for states that meet one of 
the following criteria: a) at least 150,000 population in the designated group or b) at least 100 
suicide- or homicide-related deaths among members of the designated group. 
Data for persons of Hispanic origin are limited to the District of Columbia and the 49 states that 
reported Hispanic origin of decedent on death certificates and in which reporting was at least 
80% complete during 1996-1998. Data for Oklahoma are not available because that state did not 
record Hispanic origin of decedent on death certificates in 1996. Persons of Hispanic origin can 
be of any race, and, conversely, persons listed as white, black, Asian/Pacific Islander, or 
American Indian/Alaskan Native can be Hispanic or non-Hispanic. 
The number of deaths and subsequent death rates for 1996-l 998 from suicide and homicide in 
Alaska are incorrect because NCHS did not receive changes from amended records for 1995 data 
and because errors were made when the cause-of-death data was processed. Differences are 
concentrated among selected causes of death, principally symptoms, signs, and ill-defined 
conditions (ICD-9 codes 780-799) and external causes. Also, race/ethnicity-specific death rates 
for suicide and homicide might not be accurate because race and Hispanic origin are recorded on 
death certificates by funeral directors on the basis of information provided by the next of kin. 
For more information, contact Lee Annest, Ph.D., by telephone at (770) 488-4804 or by FAX at 
(770) 488-1665, or Barbara Morrison by telephone at (770) 488-4936 or by FAX at (770) 
488-4222. 
Motor Vehicle-Related Deaths 
The ICD-9 codes for motor vehicle-related 
deaths are E810-E825. The Healthy People 
2000 goals (objective 9.3) for deaths caused 
by motor vehicle-related crashes are 14.2/ 
100,000 population and 1.5/l 00 million ve- 
hicle miles traveled (VMT j(Healthy People 
2000: national health promotion and dis- 
ease prevention objectives. 1991; DHHS 
publication no. [PHS]9 l-5021 2). 
Population-based ata are tracked by the 
NVSS. Data for the estimated motor vehicle- 
related death rate per 100 million VMT are 
tracked by the Fatal Accident Reporting Sys- 
tern (FARS) of the National Highway 
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Traffic Safety Administration, which is part 
of the U.S. Department of Transportation. 
This section provides motor vehicle-related 
mortality data per 100,000 population and 
per 100 million VMT by state, which dem- 
onstrates the relative magnitude of rates 
among states based on quartile distributions. 
Suicide 
The ICD-9 codes for suicide are E950- 
E959. 
Homicide 
The ICD-9 codes for homicide are E960- 
E969. 
ENVIRONMENTAL HEALTH CONCERNS 
Air Quality Standards 
This section shows the proportion of persons 
living in states with counties that exceeded 
U.S. Environmental Protection Agency 
(EPA) standards for air quality in 1998. The 
EPA compiles data from each state in the 
Aerometric Information Retrieval System 
(AIRS) on ambient air levels of lead, carbon 
monoxide, sulphur dioxide, nitrogen diox- 
ide, particulate matter smaller than 10 mi- 
crons, and tropospheric ozone. Because 
these pollutants pose significant threats to 
public health, they were identified in the 
Clean Air Act of 1970 and its 1977 and 
1990 amendments. The National Ambient 
Air Quality Standards (NAAQS) define 
maximum concentration levels (micrograms 
per cubic meter) that should not be exceeded 
during specific time intervals for each pol- 
lutant. 
Data are collected at state and local air pol- 
lution monitoring sites. Each site provides 
data for one or more of the six pollutants. In 
1998, there were 4,800 sites in the United 
States; most are located in heavily populated 
urban areas. Air quality for less-populated 
areas is assessed through a combination of 
data from supplemental monitors and air 
pollution models. 
This section summarizes 1998 county-level 
estimates using the EPA methodology for 
calculating single-year NAAQS exceedances 
and 1990 population data from the Bureau of 
the Census. These data represent one of the 
health status indicators developed for na- 
tional, state, and local monitoring; the con- 
verse of these proportions is addressed in 
Healthy People 2000 (objective 11.5) 
(DHHS publication no. [PHS]91-50212). 
For more information, contact Jeff Pearcy by 
telephone at (301) 458-4425 or by FAX at 
(301) 458-4036. 
Asthma 
During 1993-l 994, asthma affected 13.7 
million persons of all ages, including 6.8 
million children aged ~18 years. During 
1979-l 995, the prevalence of asthma in- 
creased 75%, from 30.7 cases/l ,000 popula- 
tion to 53.8/l ,000 population. During 1979- 
1995, the number of asthma-related eaths 
increased 98%, from 2,745 to 5,429, and the 
mortality rate increased 56%, from 11.5/ 
million population to 17.9/million popula- 
tion. For persons aged ~18 years, mortality 
increased 106%, from 1.7/million population 
to 3.5/million population. Mortality rates 
also are consistently higher among blacks 
than whites. 
During 1993-l 995, a total of 466,000 hospi- 
talizations listed asthma as the first 
discharge diagnosis; children aged ~15 years 
accounted for 164,000 (35%) of these hospi- 
talizations. In 1990, the total cost of asthma 
was estimated at $6.2 billion; inpatient hos- 
pital services alone were estimated at $1.6 
billion. The cost of hospitalizations 
increased by 47% during 1985-l 990. 
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Children miss approximately 10 million 
school days each year because of asthma. 
The loss of productivity because of parents 
who lose work days to care for children with 
asthma is estimated at $1 billion. This figure 
does not include the cost of lost productivity 
of adults who miss work because of their 
own asthma. 
A survey conducted by the Council of State 
and Territorial Epidemiologists (CSTE) in 
1996 showed that 80% of states want com- 
prehensive programs to reduce the burden of 
asthma, but do not have the resources to do 
so. 
CDC monitors national trends in asthma 
morbidity and mortality and provides techni- 
cal assistance on asthma prevention to state 
and local health agencies. CDC funds 
community-based emonstration pilot inter- 
vention programs and capacity-building pro- 
jects in several states and urban areas. CDC 
also has developed a public/private partner- 
ship in Atlanta called ZAP Asthma, which 
uses community outreach workers to help 
families implement environmental control 
measures. This model can be replicated in 
other communities, and CDC has completed 
a national strategic plan for preventing 
asthma. This plan defines the health prob- 
lem, identifies the determinants (causes and 
risk factors) and contributing factors, and 
describes the process objectives and activi- 
ties needed to address each contributing fac- 
tor. 
Despite new regulations governing pollu- 
tion, asthma continues to increase because 
most asthma triggers (e.g., indoor environ- 
mental pollutants and antigens) are not and 
cannot be regulated effectively. Reductions 
in such asthma triggers as dust mites, cock- 
roach antigen, environmental tobacco 
smoke, animal dander, respiratory 
infections, and air pollutants - coupled 
with improved medical management, educa- 
tion, and sound public health practice - can 
substantially reduce asthma irritations and 
the need for emergency medical interven- 
tion. 
For more information, contact Jim 
Rifenburg by telephone at (404) 639-2520 or 
by FAX at (404) 639-2560. 
Disabilities 
Data presented in this section are from the 
Behavioral Risk Factor Surveillance System 
(BRFSS). The BRFSS is an annual, state- 
based, random-digit-dialed telephone survey 
of health-related behavior among civilian, 
noninstitutionalized persons aged 2 18 years 
residing in the United States. In 1998, the 
BRFSS survey included a disability module 
in 16 states. This module consisted of 23 
questions, including 4 health status ques- 
tions, 10 optional quality-of-life questions, 
and 9 new disability questions. 
Disability is determined based on a) limita- 
tions in activities or cognition or b) use of 
compensatory strategies (e.g., assistance or 
adaptive devices). Sample population sizes 
in the 16 states that administered the disabil- 
ity module were increased to approximately 
3,200 to yield an expected 600-800 respon- 
dents with disabilities from each reporting 
jurisdiction. Respondents who gave a posi- 
tive response to one of the disability ques- 
tions were asked follow-up questions related 
to underlying impairment or health prob- 
lems, duration of limitation, and need for 
assistance in activities of daily living and 
instrumental activities of daily living. 
For more information, contact Don Lollar by 
telephone at (770) 488-7094 or by E-mail at 
<dcl5@cdc.gov>. 
Childhood Lead 
Poisoning Prevention 
Lead poisoning remains a major environ- 
mental public health problem for children 
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despite substantial progress in controlling 
and preventing the problem in recent years. 
During 1988-l 994, the National Health and 
Nutrition Examination Survey (NHANES) 
estimated that approximately 1.7 million 
children in the United States had blood lead 
levels (BLLs) of 2 10 pg/dL. During 1991- 
1994, NHANES .III-Phase II reported a de- 
cline in the mean BLLs for the nation. 
Despite this decline, nearly 1 million U.S. 
children are still at risk for BLLs of 2 10 
pg/dL. Public health strategies to identify 
children at greatest risk for exposure to lead 
hazards must be intensified and appropriate 
follow-up services must be provided. CDC 
provides financial assistance to state and 
local health agencies for childhood lead poi- 
soning prevention activities and for the de- 
velopment of state surveillance systems. 
In 1999, a total of 54 state and local health 
agencies were funded for childhood lead 
poisoning prevention activities, and three 
states were funded for surveillance activi- 
ties. 
Prevention activities for state and local 
health agencies comprise a comprehensive 
statewide plan that a) assesses the risk for 
lead exposure, b) responds appropriately to 
the risks identified, c) oversees and evalu- 
ates programs and policies consistent with 
risk assessment, and d) monitors screening, 
follow-up, and public and professional edu- 
cational activities. 
Surveillance activities include a) collecting, 
analyzing, and disseminating lead-related 
data and b) monitoring and evaluating the 
effectiveness of screening, follow-up, lead 
hazard control, and primary prevention ac- 
tivities. CDC also provides technical and 
management consultation to state and local 
health agencies to develop and implement 
lead poisoning prevention activities and sur- 
veillance systems. 
For more information, contact Jerry 
Hershovitz by telephone at (404) 639-2500 
or by FAX at (404) 539-2555. 
OCCUPATIONAL HEALTH CONCERNS 
Occupational Lung Disease Deaths 
Statistics in this section are from the Na- 
tional Surveillance System for Pneumoconi- 
osis Mortality (NSSPM). This system was 
developed and is maintained by the Division 
of Respiratory Disease Studies of CDC’s 
National Institute for Occupational Safety 
and Health (NIOSH). NSSPM contains 
death certificate information for 1968-I 996 
for all U.S. decedents aged 2 15 years identi- 
fied with pneumoconiosis listed as an under- 
lying or contributing cause of death. These 
data are a subset of national vital statistics 
prepared annually by CDC’s National Center 
for Health Statistics (NCHS). 
Age-adjusted pneumoconiosis -mortality 
rates are presented for each state during 
1987-l 996 (ICD-9 codes 500-505). Rates 
by specific types of pneumoconiosis (i.e., 
coal workers’ pneumoconioses [CWP], sili- 
cosis, asbestosis, byssinosis, and other/ 
unspecified pneumoconiosis) are presented 
for each state and compared with the U.S. 
rate. Population data (denominators for 
rates) are 1992 postcensal population esti- 
mates from the Bureau of the Census. 
Death rates are age-adjusted by the direct 
method to the 1940 U.S. population. More 
information on pneumoconiosis mortality 
patterns during 1987-l 996 are available in 
the Work-Related Lung Disease Surveillance 
Report 1996, which also provides data for 
other occupationally relevant respiratory 
diseases (e.g., occupational asthma, hyper- 
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sensitivity pneumonitis, malignant neoplasm 
of the pleura) (1999; DHHS publication no. 
[NIOSHIOO-1 OS). 
Traumatic Occupational Fatalities 
Occupational fatalities are identified by 
NIOSH through the National Traumatic Oc- 
cupational Fatalities (NTOF) Surveillance 
System. Information from death certificates 
is collected from 52 vital statistics reporting 
units (all 50 states, New York City, and the 
District of Columbia) according to the fol- 
lowing criteria: age 2 16 years, an external 
cause of death (ICD-9 codes E800-E999), 
and a response that the injury occurred at 
work. 
Because no standard guidelines exist for 
responding to the “Injury at work?” portion 
of a death certificate, the NTOF Surveillance 
System’s numbers should be considered the 
minimum number of work-related deaths in 
the United States during the reporting pe- 
riod. To address this issue, NIOSH collabo- 
rated with NCHS, the National Association 
for Public Health Statistics and Information 
Systems, and the National Center for Envi- 
ronmental Health (NCEH) to develop guide- 
lines for recording work-related injuries. 
These guidelines were implemented by the 
states in 1993 and should improve future 
surveillance for occupational fatalities based 
on death certificates. 
Cause-of-death codes have been assigned 
according to the ICD-9 supplementary chap- 
ter on the classification of external causes of 
injury and poisoning. Occupation narratives 
are coded into 11 divisions according to the 
1980 and 1990 Bureau of the Census classi- 
fication schemes. Denominator data for the 
calculation of rates were obtained from the 
Bureau of Labor Statistics (BLS) annual 
average employment data for 199 l-l 995. 
The rates presented in this publication are 
for the U.S. civilian labor force. 
More information is available from NIOSH 
(Fatal injuries to workers in the United 
States, 1980-I 989: a decade of surveillance 
national and state proJiles. 1993; DHHS 
publication no. [NIOSH]93-108s). 
Occupational Illnesses 
Data on occupational illness are from the 
1998 Survey of Occupational Injuries and 
Illnesses, conducted by BLS in cooperation 
with state agencies (available at 
<http://stats.bls.gov/oshhome.htm>). The
survey provided state and national estimates 
of the number and frequency of nonfatal 
occupational injuries and illnesses based on 
logs kept by 169,000 private industry em- 
ployers. It represents the most current data 
available. Data that conform to Occupational 
Safety and Health Administration (OSHA) 
definitions for mining operators in coal, 
metal, and nonmetal mining and for employ- 
ers in railroad transportation are provided to 
BLS by the Mine Safety and Health Admin- 
istration (U.S. Department of Labor) and the 
Federal Railroad Administration (U.S. De- 
partment of Transportation). 
Independent mining contractors are excluded 
from data for the mining industry. The sur- 
vey also excludes farms with 4 1 employees 
and persons who are self-employed or em- 
ployed in private households. 
Forty-one states participated in this project. 
Nonparticipating states include Colorado, 
Idaho, Mississippi, New Hampshire, North 
Dakota, Ohio, Pennsylvania, South Dakota, 
and Wyoming. The District of Columbia 
also did not participate. 
Illnesses are reported by employers in seven 
categories. Industries are coded into 10 cate- 
gories according to the 1987 edition of the 
Standard Industrial ClassljTcation Manual, 
published by the U.S. Office of Management 
and Budget (1987). 
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Overall, BLS reported that the U.S. rate for 
occupational injuries and illnesses in private 
industry was 6.7/100 full-time workers in 
1998. Approximately 392,000 new cases of 
occupational illness were reported in private 
industry in 1998. Manufacturing industries 
accounted for three-fifths of these cases. 
Disorders associated with repeated trauma 
(e.g., carpal tunnel syndrome and noise- in- 
duced hearing loss) represented 65% of the 
392,000 cases of illness reported. 
INFECTIOUS DISEASES 
Acquired lmmunodeficiency 
Syndrome 
This section provides estimated rates per 
100,000 population for adults and adoles- 
cents (i.e., persons aged 2 13 years) living 
with acquired immunodeficiency 
syndrome (AIDS) (i.e., AIDS prevalence) at 
the end of 1999, by state of residence. The 
prevalence of AIDS is a function of the 
number of incident cases and the length of 
time persons survive after an AIDS diagno- 
sis. At the end of 1999, approximately 
320,000 persons were alive and living with 
AIDS in the United States. Although the 
annual number of new AIDS diagnoses has 
decreased, largely as a result of recent devel- 
opments in treatment for human immunode- 
ficiency virus (HIV) infection, AIDS preva- 
lence increased by approximately 25,000 
persons from 1997 through 1998 and by 
approximately 27,000 from 1998 through 
1999 because of longer survival times after 
diagnosis. 
AIDS-related organizations at federal, state, 
and local levels of government, as well as 
some businesses and community groups, 
rely on current AIDS information to plan for 
the future. Because of decreases in AIDS 
incidence, recent data on the number of per- 
sons living with AIDS allow better planning 
for future fiscal requirements, along with 
medical and social service needs. 
States report AIDS cases to the Division of 
HIV/AIDS Prevention (DHAP) of CDC’s 
National Center for HIV, STD, and TB Pre- 
vention (NCHSTP). A uniform case defini- 
tion and case report form are used, and rates 
are calculated on an annual basis per 
100,000 population. Population data are 
1999 postcensal population estimates from 
the Bureau of the Census. 
Rates per 100,000 population also are in- 
cluded for, at most, the four largest Metro- 
politan Statistical Areas (MSAs) in states 
with the highest case rates for AIDS. For 
states that do not have MSAs with popu- 
lations of r500,000, no MSA data are pro- 
vided. MSAs sometimes cross state lines. In 
these instances, the data are assigned to the 
state with the largest proportion of the 
MSA’s population. Definitions and descrip- 
tions of MSAs are available on the Bureau 
of the Census Internet site at the following 
address: <http://www.census.gov>. 
For more information, contact a DHAP In- 
formation Specialist by telephone at (404) 
639-2072 or by FAX at (404) 639-2007. In- 
formation also is available on the DHAP 
Internet site at the following address: 
<http://www.cdc.gov/iv/dhap.htm>. 
Malaria 
The National Malaria Surveillance System is 
a passive reporting system operated by the 
Malaria Epidemiology Branch in the Divi- 
sion of Parasitic Diseases of CDC’s National 
Center for Infectious Diseases (NCID). 
Laboratory-confirmed cases of malaria are 
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identified by health-care providers or labora- 
tories, reported to local and state health de- 
partments, then reported to CDC. Approxi- 
mately 1,500 cases of malaria are reported in 
the United States each year, but many addi- 
tional cases might go unreported because of 
underreporting. Most infections are acquired 
outside the Uni-ted States and its territories, 
in parts of the world where malaria is en- 
demic. Typically, ~10 cases each year are 
acquired inside the United States, usually 
from transfusion, needlestick, organ trans- 
plantation, congenital transmission, or an 
infected mosquito. 
Travelers visiting countries where malaria is 
endemic can minimize their risk by taking 
an antimalarial drug for chemoprophylaxis 
and using personal protection measures (e.g., 
insect repellents, protective clothing, and 
mosquito nets). Information regarding ma- 
laria risk, antimalarial drug-resistance pat- 
terns, and recommended antimalarial pro- 
phylaxis is available in CDC’s Health Infir- 
mation for International Travel, 1999-2000. 
Current recommendations are also available 
free on the Internet at 
<http://www.cdc.gov/travel>, by calling 
(888) 232-3228, or by calling (888) 
232-3299 to request information by fax. 
Although sustained malaria transmission no 
longer occurs in this country, anopheline 
mosquitoes capable of transmitting the in- 
fection are still found in all 48 of the contig- 
uous United States. These insects rarely en- 
counter malaria-infected humans, and they 
typically do not survive long enough to be- 
come infective, bite another person, and 
transmit the infection. However, when 
weather conditions are favorable (e.g., sus- 
tained periods of high temperature and hu- 
midity), these mosquitoes can survive longer 
and become infective more quickly. 
Mosquito-transmitted malaria occurs in the 
United States only when certain events coin- 
cide (e.g., a person with parasitemia, 
increased contact among humans and the 
anopheline vector, and environmental condi- 
tions that favor transmission) (Emerg Infect 
Dis 1996;2:3743). 
Annual reports from the National Malaria 
Surveillance System are printed in the CDC 
Surveillance Summaries (MMWR 
1999;48[SS-11). These reports include sum- 
mary data on reported cases and their origins 
and information on locally acquired cases 
investigated during the year. 
For more information, contact the Malaria 
Hotline by telephone at (770) 488-7788 or 
by FAX at (770) 488-776 1. 
Chlamydia and Gonorrhea 
Primary and Secondary Syphilis 
Data in these sections are from state and 
local health departments, which report cases 
of chlamydia, gonorrhea, and primary and 
secondary syphilis to the Division of Sexu- 
ally Transmitted Disease (STD) Prevention, 
NCHSTP. Crude incidences (new cases/ 
population) are calculated annually per 
100,000 population. Rates for 1999 use 1998 
population estimates from Bureau of the 
Census postcensal data. Because no cases of 
chlamydia were reported outside New York 
City, the rate of occurrence of chlamydia for 
the state of New York reflects only the oc- 
currence of cases in New York City. 
More detailed information on STDs is avail- 
able in CDC’s Sexually Transmitted Disease 
Surveillance, I999 (September 2000). Cop- 
ies can be obtained from the Office of Com- 
munications, NCHSTP; CDC; 1600 Clifton 
Road, Mailstop E-06; Atlanta, GA 30333. 
The report is also available on the Internet at 
<http://www.cdc.gov/nchstp/dstd/ 
Stats_Trends/l999SurvRpt.htm>. 
For more information, contact Melinda 
Flock, M.S.P.H., by telephone at (404) 
639-8356 or by FAX at (404) 639-8611. 
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Information also is available on the Division 
of STD Prevention website at the following 
address: <http://www.cdc.gov/nchstp/dstd>. 
Pneumonia and Influenza Deaths 
Data for the total number of deaths and age- 
adjusted death rates for pneumonia and in- 
fluenza (P&I) (ICD-9 codes 480-487) are 
from the Nationd Vital Statistics Report 
(2000;48[ 111). P&I death rates are presented 
by race/ethnicity for states that meet one of 
the following criteria: a) 2 150,000 persons 
in the designated group or b) 220 deaths 
among members of the designated group. 
Data for Oklahoma are not available because 
that state did not record Hispanic origin of 
decedent on death certificates in 1996. 
Nearly all of the infectious diseases that 
were among the 10 leading causes of death 
in the United States at the beginning of the 
twentieth century are now under control 
(e.g., tuberculosis, diphtheria, and diarrhea1 
diseases). However, P&I have continuously 
been among the top 10 leading causes of 
death since the beginning of the 199Os, and 
they remain a serious health problem. In 
1998, P&I ranked sixth among the 10 lead- 
ing causes of death. 
Minor changes in the antigenicity of influ- 
enza viruses, known as antigenic drift, lead 
to influenza epidemics nearly every winter 
in the United States. An average of approxi- 
mately 20,000 deaths, more than 110,000 
hospitalizations, millions of visits for outpa- 
tient care, and tens of millions of lost work 
and school days occur each influenza sea- 
son. 
Influenza vaccine is the primary method for 
preventing influenza infection and its more 
severe complications. This inactivated (i.e., 
killed-virus) vaccine contains three strains 
(two type A and one type B), representing 
the influenza viruses likely to circulate in the 
United States during the upcoming winter. 
Vaccination is strongly recommended for all 
persons aged 26 months who are at 
increased risk for complications because of 
age or an underlying medical condition 
(MMWR 2000;49[RR-31). 
Active global and U.S. surveillance for in- 
fluenza viruses is critical for formulating 
each year’s vaccine and detecting new vi- 
ruses. Surveillance for influenza-like illness 
and mortality caused by P&I is an important 
way to assess the impact of the circulating 
strain(s). 
In addition to causing annual epidemics, 
new influenza type A viruses to which most 
of the world’s population are susceptible can 
emerge unpredictably and lead to pan- 
demics. In the twentieth century, three pan- 
demics (during the 1918-19, 1957-58, and 
1968-69 seasons) caused great increases in 
illness and more than 650,000 deaths com- 
bined. In 1997 and 1999, human cases of 
illness and deaths related to new influenza 
viruses were discovered but did not result in 
pandemics. 
Pneumococcal infections are the most com- 
mon cause of bacterial meningitis and of 
pneumonia leading to hospitalization. Each 
year, pneumococcus causes approximately 
60,000 cases of bacteremic disease, 3,000 
cases of meningitis, 125,000 cases of pneu- 
monia requiring hospitalization, and 6 mil- 
lion ear infections. Approximately 1 in 10 
persons with an invasive pneumococcal in- 
fection (i.e., infection of the blood stream or 
other normally sterile body site) die of the 
infection (range: from <l in 100 children 
aged ~5 years to approximately 1 in 6 adults 
aged ~65 years) (CDC. Active Bacterial 
Core Surveillance [ABCs] Report, Strepto- 
coccus pneumoniae, 1999. Available on the 
Internet at <http://www.cdc.gov/ncidod/ 
dbmd/abcs>). 
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Multidrug-resistant pneumococci are becom- 
ing increasingly common, making 
pneumococcal infections more difficult to 
treat. CDC surveillance data suggest hat 
approximately one-quarter of invasive 
pneumococcal isolates are no longer suscep- 
tible to penicillin and approximately 1 in 7 
are not susceptible to at least three drug 
classes (New Engl J Med 2000;343 : 19 17- 
24). Infants and young children, persons 
aged 265 years, persons with immune sys- 
tem disorders, and persons with certain 
chronic diseases are at higher risk for 
pneumococcal infections. 
A 23-valent pneumococcal polysaccharide 
vaccine is recommended for persons aged 
22 years who are at high risk. A 7-valent 
vaccine effective for infants and young chil- 
dren was licensed in February 2000 and is 
recommended for all children aged ~2 years 
and for some children aged 2-4 years at high 
risk (MY. 2000;49[No. RR-91). 
The Public Health Service publication 
Healthy People 2010 (objective 14-29) calls 
for increasing P&I vaccination levels to a) 
2 90% among persons aged 2 65 years and 
persons of all ages in long-term-care or 
nursing homes and b) 260% among persons 
aged 18-64 years at high risk for complica- 
tions from pneumococcal disease or influ- 
enza infection (Healthy people 2010. Con- 
ference ed, in 2 ~01s. Washington, DC: US 
Department of Health and Human Services, 
2000). The Healthy PeopZe 2000 goal (ob- 
jective 20.11) for P&I vaccination was 60% 
for noninstitutionalized populations at high 
risk and 80% for long-termsare and nursing 
home residents (199 1; DHHS publication 
no. [PHS]91-50212). 
During 1989-l 999, pneumonia and influ- 
enza vaccination levels in the United States 
increased. Analysis of data from the 1999 
Behavioral Risk Factor Surveillance System 
(The BRFSS) indicates that 67% of 
noninstitutionalized persons aged 2 65 years 
reported receiving influenza vaccination 
during the preceding 12 months, which ex- 
ceeds the Healthy People 2000 objective. 
(BRFSS is an annual, state-based, random- 
digit-dialed telephone survey of health-re- 
lated behavior. Each participating state se- 
lects a probability sample of its non-institu- 
tionalized civilian adult population aged 2 18 
years who have telephones. During 1999, all 
50 states, the District of Columbia, and 
Puerto Rico participated in the BRFSS.) 
By contrast, influenza vaccination rates are 
lower among adults aged 18-64 years who 
are at high risk for complications. Based on 
1997 National Health Interview Survey 
(NHIS) data, 1997 influenza vaccination 
coverage for persons in this age group at 
high risk was 26% (CDC, unpublished data, 
1997). 
Although pneumococcal vaccine coverage 
has increased during the 199Os, coverage in 
most states and the United States as a whole 
remains below Healthy People 2000 goals. 
The 1999 BRFSS report notes that only 54% 
of persons aged ~65 years reported ever re- 
ceiving a dose of pneumococcal vaccine. In 
individual states, coverage ranged from 40% 
to 67%, and 8 states had 260% coverage. 
Based on the 1997 NHIS, pneumococcal 
vaccination coverage for persons at high risk 
aged 18-64 years was 13% (CDC, unpub- 
lished data, 1997). 
For more information on pneumococcal in- 
fections, contact Cynthia Whitney, M.D., 
M.P.H., by telephone at (404) 639-2215 or 
by FAX at (404) 639-3970. For more infor- 
mation on influenza infections, contact 
Alicia S. Postema, M.P.H., by telephone at 
(404) 639-3747 or by FAX at (404) 
639-3866. For more information on vaccine 
issues, contact James A. Singleton, M.S., by 
telephone at (404) 639-8257 or by FAX at 
(404) 639-8616. 
Lyme Disease 
Lyme disease is a multisystem, multistage 
disease caused by infection with the tick- 
borne spirochete, Borrelia burgdorferi, and 
the most commonly reported vectorborne 
disease in the United States. During 1999, a 
total of 16,273 cases of Lyme disease were 
reported to CDC (cases are reported by 
county of residence, which is not necessarily 
the county of exposure). 
CDC initiated national surveillance for 
Lyme disease in 1982, and 11 states reported 
491 cases. During 1992-1998, cases 
increased 70%, from 9,986 in 1992 to 
16,802 in 1998, with a total of 88,967 cases 
reported to CDC’s National Notifiable Dis- 
eases Surveillance System (NNDSS) during 
this period (MMWR 2000;49[No.SS- 
31: l-l 1). Although cases were reported by 
all states except Montana, 92% were 
reported from only 10 states (Connecticut, 
Delaware, Massachusetts, Maryland, Minne- 
sota, New Jersey, New York, Pennsylvania, 
Rhode Island, and Wisconsin) (MMWR 
2000;49[No.SS-3]:1-11). The tick vector in 
these endemic areas is the deer tick or Ixodes 
scapularis. 
A vaccine against Lyme disease was 
licensed in December 1998 for persons aged 
15-70 years (MMWR 1999;48[No. RR-71). 
CDC is funding community-based programs 
to prevent Lyme disease through health edu- 
cation, appropriate vaccination, and inte- 
grated strategies to reduce vector tick densi- 
ties. 
A skin rash that resembles the one caused by 
Lyme disease has been associated with bites 
by the lone star tick (Amblyomma merica- 
num), but this rash does not appear to be 
caused by B. burgdorferi infection (J Infect 
Dis 1995; 172:470-80 and Arch Intern A4ed 
1997;157:263541). CDC is conducting 
studies to determine the etiology of this con- 
dition, which occurs primarily in the south- 
central and southeastern United States and 
could be mistakenly reported as Lyme dis- 
ease. 
For more information, contact CDC’s Lyme 
disease program by telephone at (970) 
221-6400 or by FAX at (970) 221-6474. 
Information is also available on the Internet 
at <http://www.cdc.gov/ncidod/dvbidl 
lymeinfo.htm>. 
Tuberculosis 
Data in this section are from health depart- 
ments in all 50 states, New York City, and 
the District of Columbia, which report tuber- 
culosis (TB) cases to the Division of Tuber- 
culosis Elimination, NCHSTP. Rates were 
calculated using postcensal estimates from 
the Bureau of the Census. 
In 1999, a total of 17 states had TB case 
rates of 13.5 cases/lOO,OOO population. This 
rate represents the interim target for the year 
2000 established by the Advisory Council 
for the Elimination of Tuberculosis as part 
of its long-term goal to eliminate TB by 
2010. Fifteen states and the District of Co- 
lumbia had TB case rates higher than the 
1999 national rate of 6.4 cases/lOO,OOO pop- 
ulation. 
Eliminating TB in the United States will 
depend increasingly on eliminating TB 
among persons born in countries with high 
TB rates (MMWR 1998;47[No. RR-161). 
The proportion of TB cases among foreign- 
born persons living in the United States in- 
creased from 27% in 1992 to 43% in 1999 
and was 2 50% in 15 states. 
For more information, contact Gloria Kelly 
by telephone at (404) 639-8 117 or by FAX 
at (404) 639-8959. Information also is avail- 
able on the Division of TB Elimination 
Internet site at <http://www.cdc.gov/nchstp/ 
tb/default.htm>. 
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CHRONIC DISEASES: CONDITIONS AND RISK FACTORS 
This section presents mortality data for total cardiovascular disease, breast cancer, colon cancer, 
and lung cancer, as well as related risk factor data for these and other chronic diseases. In 1999, 
CDC’s National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) 
published Chronic Diseases and Their Risk Factors: The Nation 3 Leading Causes of Death 
(December 1999). This report provides state-specific data for the major causes of death, 
cardiovascular disease, cancer, and diabetes, as well as for selected risk factors and the use of 
preventive services. A second report, Unrealized Prevention Opportunities: Reducing the Health 
and Economic Burden of Chronic Disease (November 2000), lists national priorities for 
preventing chronic disease and describes ways to reduce the health-care and economic burdens of 
chronic disease. Copies of both documents are available from NCCDPHP by telephone at (770) 
4885131. 
For more information, contact Nora Keenan, Ph.D., by telephone at (770) 4885414, by FAX at 
(770) 488-8 15 1, or by E-mail at <NKeenan@cdc.gov>. Information regarding the major chronic 
diseases and their risk factors also is available on the NCCDPHP Internet site at 
<http://www.cdc.gov/nccdphp>. 
Data for death rates are annual age-adjusted rates based on the underlying cause of death for the 
years indicated. The numbers of deaths (numerators for death rates) are from the National Vital 
Statistics System (NVSS) of CDC’s National Center for Health Statistics (NCHS) and are based 
on data provided by registrars in all 50 states, New York City, and the District of Columbia. The 
numbers of deaths sometimes differ from those published by the states because a) the cut-off 
dates for accepting vital statistics records into the annual file for producing statistics can be 
different; b) the interstate exchange program through which states receive data on events that 
involved residents but occurred in other states might not include all records; and c) the intema- 
tional rules for selecting the underlying cause of death is interpreted and applied differently in 
some states. 
Population data (denominators for death rates) are 1998 postcensal population estimates from the 
Bureau of the Census. Death rates are age-adjusted to the 1940 U.S. population by the direct 
method. Direct age-adjustment is calculated by weighting the annual age-specific rates by the 
population distribution in the standard population (see the Mortality section for more information 
on population data and age adjustment). 
All risk factor data presented in this section, as well as the data on oral health, clinical breast 
exam, mammography, and proctoscopy, were obtained from the Behavioral Risk Factor 
Surveillance System (BRFSS). The BRFSS is an annual, state-based, random-digit-dialed 
telephone survey of health-related behavior. Each participating state selects a probability sample 
of its noninstitutionalized civilian adult population (i.e., persons aged 2 18 years) who have 
telephones. In 1999, all 50 states, the District of Columbia, and Puerto Rico participated in the 
BRFSS. 
For more information, confact Eve Powell-Griner, Ph.D., by telephone at (770) 488-2524 or by 
FAX at (770) 488-8150. More information about the BRFSS is available on the NCCDPHP 
Internet site at <http://www.cdc.gov/nccdphp>. 
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National objectives for several behavioral risk factors discussed in this section are from the 
Public Health Service publication Healthy People 2000: National Health Promotion and Disease 
Prevention Objectives (1991; DHHS publication no. [PHS]91-50212). 
These objectives include the following: 
Objective 1.5 - Reduce to I 15% the proportion of persons aged r 6 years who engage in no 
leisure-time physical activity. 
Objective 2.3 - Reduce overweight to a prevalence of 120% among persons aged 220 years. 
Objective 2.6 - Increase to 250% the proportion of persons aged 22 years who meet the average 
daily goal of 25 servings of vegetables and fruits. The 50% target was added in the 1995 
midcourse revision of Healthy People 2000: Midcourse Review and I995 Revisions. The average 
daily goal of 25 servings of vegetables and fruits comes from the Dietary Guidelines for 
Americans. Third Edition (1990; DHHS publication no. 1990-273-930). 
Objective 3.4 - Reduce cigarette smoking to a prevalence of I 15% among persons aged 220 
years. 
Objective 13.4 - Reduce to 120% the proportion of persons aged 2.65 years who have lost all of 
their natural teeth. 
Objective 13.14 - Increase to 270% the proportion of persons aged 2.35 years using the oral 
health-care system during each year. 
Oral Health 
Loss of all natural permanent eeth (edentul- 
ism) can have a substantial negative effect 
on quality of life, self-image, and daily func- 
tioning. Tooth loss can be prevented through 
education, regular dental care, and early 
diagnosis and prompt treatment of diseases 
and conditions that lead to tooth loss. The 
HeaZthy People 2000 goal (objective 13.4) is 
to reduce to ~20% the proportion of persons 
aged 265 years who have lost all of their 
natural teeth. 
Prevalence estimates for total tooth loss 
among persons aged 265 years are based on 
1999 BRFSS data. Participants were asked 
how many of their permanent eeth were 
removed because of tooth decay or gum 
disease. 
. 
Regular dental visits are opportunities for 
prevention, early diagnosis, treatment, and 
health education. Adults who do not receive 
regular professional care can develop oral 
diseases that lead to unnecessary restorative 
treatment and preventable tooth loss. Even 
edentate persons remain at risk for oral soft 
tissue lesions and denture-related problems. 
Healthy People 2000 objective 13.14 is to 
increase to 2 70% the proportion of persons 
aged 2 3 5 years using the oral health-care 
system each year. 
In states that administered the BRFSS oral 
health module, participants were asked how 
long it had been since they last visited a den- 
tist or dental clinic. Estimates of the propor- 
tion of persons aged 2 3 5 years who reported 
that they saw a dentist during the preceding 
12 months are presented for 48 states that 
administered the oral health module during 
at least 1 year during 1995-1999. To 
increase the precision of prevalence esti- 
mates, data from multiple years were aggre- 
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gated for states that administered the BRFSS 
oral health module during more than 1 year. 
Estimates of the proportion of persons aged 
2 35 years who reported visiting a dentist 
during the preceding 12 months are based on 
1999 BRFSS data. Participants were asked 
how long it had been since they last visited a 
dentist or dental clinic. 
For more information, contact William 
Konn, D.D.S., by telephone at (770) 
488-6071, by FAX at (770) 488-6080, or by 
E-mail at <wak4@cdc.gov>. 
Prevalence of Diagnosed Diabetes 
This section presents age-specific and total 
prevalence of diagnosed diabetes for the 
state and for the BRFSS median value (50th 
percentile) for all states. The percentage of 
the population with diagnosed diabetes is a 
3-year average of BRFSS data for 1997- 
1999. Persons with diagnosed diabetes are 
defined as those who report that a physician 
told them they have diabetes. 
For more information, contact Linda Geiss, 
M.A., by telephone at (770) 488-1056, by 
FAX at (770) 488-l 148, or by E-mail at 
<Isg2@cdc.gov>. 
Prevalence of Physical Inactivity 
and Overweight 
Physical inactivity and overweight are con- 
sidered important risk factors for coronary 
heart disease and other chronic diseases. 
Reducing to 5 15% the proportion of persons 
aged 26 years who engage in no leisure-time 
physical activity and reducing the prevalence 
of overweight to 120% among persons aged 
220 years are Healthy People 2000 goals 
(objectives 1.5 and 2.3, respectively). The 
average 3-year prevalence of physical inac- 
tivity and overweight are presented for each 
state and the District of Columbia, in rela- 
tion to Healthy People 2000 objectives. 
Leisure-time physical inactivity is defined as 
not participating in any leisure-time physical 
activities or exercises (e.g., running, calis- 
thenics, golfing, gardening, or walking) dur- 
ing the previous month. Overweight is de- 
fined as body mass index 2 27.8 kg/m* for 
men and 2 27.3 kg/m* for women. 
Estimates of leisure-time physical inactivity 
and overweight are calculated by taking the 
average prevalence for 1994, 1996, and 
1998. These years were chosen because 
physical activity data are not available for 
1995,1997, and 1999. 
For more information, contact Anita 
Blankenship by telephone at (770) 
488-5680, by FAX at (770) 488-5473, or by 
E-mail at <aob4@cdc.gov>. 
Total Cardiovascular Disease 
The age-adjusted eath rates for total cardio- 
vascular disease per 100,000 population for 
1998 are provided for all 50 states and the 
District of Columbia. The ZCD-9 codes for 
cardiovascular disease as the underlying 
cause of death are 390-459. These cardio- 
vascular diseases include rheumatic fever/ 
rheumatic heart disease (ICD-9 codes 
390-398); hypertensive heart disease (ICD-9 
code 402); hypertensive heart and renal dis- 
ease (ICD-9 code 404); ischemic heart dis- 
ease (ICD-9 codes 4 1 O-4 14); diseases of 
pulmonary circulation, including acute pul- 
monary heart disease, chronic pulmonary 
heart disease, and other conditions (ICD-9 
codes 4 15-4 17); other forms of heart dis- 
ease, including heart failure (ICD-9 codes 
420-429), stroke (ICD-9 codes 430-438), 
diseases of the arteries, arterioles, and capil- 
laries (ICD-9 codes 44w48), and diseases 
of the veins and lymphatics; and other dis- 
eases of the circulatory system (ICD-9 codes 
45 1459). 
The state-based, self-reported prevalence 
estimates for four behavioral risk factors for 
cardiovascular disease are based on the 1999 
BRFSS. For each risk factor, the state value 
is compared with the BRFSS median value 
(50th percentile) for all states and the nu- 
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merical value from the corresponding 
Healthy People 2000 objective. These risk 
factors and their objectives are current 
smoking (objective 3.4), overweight (objec- 
tive 2.3), eating ~5 servings of fruits and 
vegetables a day (objective 2.6), and physi- 
cal inactivity (objective 1.5). 
For this section, current smokers are defined 
as persons who report smoking 2 100 ciga- 
rettes during their lifetime and who report 
smoking every day or some days. 
Overweight is calculated based on self-re- 
ported weight and height and is defined as 
body mass index 2 27.8 kg/m* for men and 
227.3 kg/m* for women. Persons classified 
as physically inactive reported not participat- 
ing in any leisure-time physical activities or 
exercises (e.g., running, calisthenics, golf- 
ing, gardening, or walking) during the previ- 
ous month. 
For more information, contact Carma Ayala, 
Ph.D., by telephone at (770) 488-8072, by 
FAX at (770) 488-8 15 1, or by E-mail at 
<cial@cdc.gov>. 
Breast Cancer and Mammography 
This section presents annual age-adjusted 
death rates for breast cancer as the underly- 
ing cause of death for women during 1988- 
1998 for each state and the United States as 
a whole in relation to the Healthy People 
2000 target of ~20.6 deaths/lOO,OOO women 
(objective 16.3). The ICD-9 code for breast 
cancer is 174. 
The section on clinical breast exam and 
mammography presents BRFSS data for 
1994-1999 for each state and the BRFSS 
median value (50th percentile) for all states. 
The BRFSS data for this section are based 
on women aged 250 years who reported 
having had a clinical breast examination and 
a mammogram within the preceding 2 years 
either as part of a routine check up or be- 
cause of a breast condition (e.g., cancer or a 
lump in the breast). The denominator ex- 
cludes respondents who refused to answer 
the questions on clinical breast exam or 
mammography and those who answered that 
they did not know or were not sure of the 
answer to these questions. 
For more information, contact Steve L. 
Reynolds, M.P.H., by telephone at (770) 
488-3075, by FAX at (770) 488-4760, or by 
E-mail at <slr6@cdc.gov>. 
Colorectal Cancer and Proctoscopy 
The annual age-adjusted eath rates for colo- 
rectal cancer as the underlying cause of 
death are presented for 1988-l 998 for the 
states by sex and by total deaths in relation 
to the Healthy People 2000 target of I 13.2 
deaths/l 00,000 persons (objective 16.5). The 
ICD-9 codes for colorectal cancer are 
153.0-154.3, 154.8, and 159.0. 
The section on proctoscopy presents BRFSS 
data for 1995 and 1997 for the states and the 
BRFSS median value (50th percentile) for 
all states. The BRFSS data for this section 
are based on survey respondents aged 250 
years who reported ever having had a proc- 
toscopic exam for signs of cancer or other 
health problems. 
For more information, contact Steven L. 
Reynolds, M.P.H., by telephone at 
(770) 488-3075, by FAX at (770) 488-4760, 
or by E-mail at <slr6@cdc.gov>. 
Lung Cancer and Current Smoking 
The annual age-adjusted eath rates for lung 
cancer as the underlying cause of death are 
presented for 1988-1998 for the states by 
sex and by total deaths in relation to the 
Healthy People 2000 target of 142 deaths/ 
100,000 persons (objective 16.2). The ICD-9 
codes for lung cancer are 162.2-162.9. 
The section on current cigarette smoking 
among persons aged 2 18 years is based on 
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BRFSS data for 1993-1997. Current smok- 
ers are defined as persons who report smok- 
ing 2 100 cigarettes during their lifetime and 
who report smoking every day or some days. 
Results are presented by sex and total popu- 
lation in relation to the HeaZthy People 2000 
target of reducing cigarette smoking to 
I 15% among this population (objective 3.4). 
For more information, contact Pascale 
Wortley, M.D., M.P.H., by FAX at 
(770) 4885848, or by E-mail at 
.<PWortley@cdc.gov>. 
Prevalence of Smoking 
This section presents 1999 BRFSS data on 
current cigarette smoking by demographic 
groups in relation to the Healthy People 
2000 target of reducing cigarette smoking to 
< 15% among current smokers (objective 
3.4). Reported prevalences are BRFSS esti- 
mates for persons aged r 18 years. 
Current smokers are defined as persons who 
report smoking 2 100 cigarettes during their 
lifetime and who report smoking every day 
or some days. Demographic groups are 
based on self-reporting of age, sex, edu- 
cational attainment, race, and Hispanic eth- 
nicity. Women aged 18-44 years represent 
women of reproductive age. The lower age 
limit was used because the BRFSS does not 
survey persons aged ~18 years. 
Smoking prevalence for persons of Hispanic 
ethnicity and for black, American Indian/ 
Alaskan Native, and Asian/Pacific Islander 
racial groups is not reported for states with 
60 respondents in their BRFSS sample for 
those racial/ethnic groups in 1999. Thus, the 
BRFSS median for smoking prevalence for 
racial/ethnic groups is calculated based on 
data from states with -z 50 respondents from 
a particular group. 
Survey respondents who declined to answer 
questions regarding smoking are excluded 
from the denominator of this analysis, which 
might explain slight differences between 
these and other estimates. 
For more information, contact Pascale 
Wortley, M.D., M.P.H., by FAX at (770) 
488-5848, or by E-mail at 
<PWortley@cdc.gov>. 
Prevalence of Not Having 
Health-Care Coverage 
This section presents 1999 BRFSS data on 
persons aged 18-64 years who do not have 
health-care coverage, by race and Hispanic 
ethnic@. Participants were asked, “Do you 
have any kind of health care coverage, in- 
cluding health insurance, prepaid plans such 
as HMOs, or government plans such as 
Medicare?’ 
The prevalence of not having health-care 
coverage for persons of Hispanic ethnicity 
and for black, American Indian/Alaskan 
Native, and Asian/Pacific Islander racial 
groups is not reported for states with ~50 
respondents in their BRFSS sample for those 
racial/ethnic groups in 1999. Thus, the 
BRFSS median for health-care coverage for 
racial/ethnic groups is calculated based on 
data from states with 2 50 respondents from 
a particular group. 
For more information, contact Nora Keenan, 
Ph.D., by telephone at (770) 488-5414, by 
FAX at (770) 48 l-508 1, or by E-mail at 
<Nkeenan@cdc.gov>. 
HEALTH PROMOTION STRATEGIES 
Training Networks 
The Public Health Training Network 
(PHTN) information for this section is from 
a database of registrants in distance-based 
learning courses who later received con- 
tinuing education credits. For more informa- 
tion, contact Dennis McDowell by telephone 
at (404) 639-3707 or by FAX at (404) 
639-3982. Information is also available on 
the PHTN Internet site at the following ad- 
dress: <http://www.cdc.gov/phtn/>. 
The National Laboratory Training Network 
(NLTN) information for this section is from 
a database of registrants in training activities 
sponsored by NLTN. For more information, 
contact Judy Delany, M.S., by telephone at 
(770) 488-8063, by FAX at (770) 488-8278, 
or by E-mail at <jdelany@cdc.gov>. Infor- 
mation also is available on the Internet at 
<http://www.phppo.cdc.gov/dls/nltn>. 
Adult Vaccination Coverage 
Data in this section indicate the percentage 
of persons aged 265 years who reported hav- 
ing a vaccination for influenza during the 
preceding year or ever having a vaccination 
for pneumococcal disease. Data are from the 
1999 Behavioral Risk Factor Surveillance 
System (BRFSS), which is an annual, state- 
based, random-digit-dialed telephone survey 
of health-related behavior. Each participat- 
ing state selects a probability sample of its 
noninstitutionalized civilian adult population 
(aged 2 18 years) who have telephones. In 
1999, all 50 states, the District of Columbia, 
and Puerto Rico participated in the BRFSS. 
For more information on pneumonia and 
influenza mortality, Healthy People 2000 
objectives, and other vaccination coverage 
data, see pages 73-74. 
For more information on influenza and 
pneurnococcal vaccination levels, contact 
James A. Singleton by telephone at 
(404) 639-8689, by FAX at (404) 639-8616, 
or by E-mail at <JSingleton@cdc.gov>. 
